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Low-grade inflammation, as measured by C-reactive protein levels, has been 
shown to associate with chronic diseases, such as atherosclerosis and metabo-
lic syndrome and also with allergic diseases. However, low-grade inflammation 
may also be beneficial and contribute to the development of healthy immune 
system. Farming environment in early life has been shown to protect from al-
lergic diseases but the mechanisms behind the protective effect are unknown. 
On the other hand, moisture damage and mould in buildings are associated 
with adverse health effects. The objective in the present study was to investi-
gate what the environmental factors that could induce inflammation are and 
to find out if there is an association between systemic low-grade inflammation 
and the development of allergic diseases in children. Blood, faecal and fractio-
nal exhaled nitric oxide samples were collected, home inspection for moisture 
damage was carried out and children’s health and environmental exposures 
were followed by questionnaires.
Farming environment did not induce systemic low-grade inflammation 
but there were associations between systemic inflammation and moisture 
damage in home. Some environmental factors may associate with low-grade 
inflammation in atopic and non-atopic children differently. The results suggest 
that low-grade inflammation may protect from atopic deviation among non-
atopic children. In contrast to the low-grade inflammation, a high degree of 
intestinal inflammation during the first months of life predicts the develop-
ment of allergic diseases. In summary, the results provide new insights into the 
development of allergic diseases and furthermore, the study shows that mois-
ture damage in the home increases CRP levels and proinflammatory cytokine 
production in children.
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Abstract 
Kirsi Mustonen, The role of inflammation and its environmental triggers in allergic 
diseases. National Institute for Health and Welfare (THL). Research 140. 258 pages. 
Kuopio, Finland 2014. 
ISBN 978-952-302-324-6 (printed); ISBN 978-952-302-325-3 (pdf) 
 
Systemic low-grade inflammation, typically defined as the increased production of 
C-reactive protein (CRP) below the levels seen in clinical infections, plays a role not 
only in the immune-mediated diseases, but also in other chronic diseases, such as in 
atherosclerosis and in metabolic syndrome, obesity and asthma. On the other hand, 
low-grade inflammation may also be beneficial and contribute to the development of 
healthy immune system as suggested by the studies showing that low-grade 
inflammation may protect from allergic diseases. Farming environment in early life 
has been suggested to protect from atopy and allergic diseases but the mechanisms 
behind the protective effect are still unrevealed. Microbial exposure in our 
environment, e.g. non-pathogenic microbes in the farming environment, could cause 
detectable systemic low-grade inflammation. On the other hand, moisture damage 
and mould in buildings are associated with adverse health effects, but again the 
mediators of the harmful effects are not known yet.  
The main aim of this thesis was to investigate if there is an association between 
systemic low-grade inflammation and the development of allergic diseases in 
children and could environmental exposures cause systemic low-grade inflammation 
in children. In addition, other markers of inflammation were explored. 
The research was based on two birth cohorts, the international PASTURE study 
and the Finnish LUKAS study. Inflammatory markers were collected via blood or 
faecal samples at the ages of two months, one, 4.5 and six years and the data on the 
children’s health, confounding factors and potential environmental microbial and 
farming exposures were collected by questionnaires up to the age of six years.  
Among the children who were non-atopic at the age of one, the risk of atopy at 
the age of 4.5 years was significantly lower among those with a concentration of 
CRP in the highest quartile (aOR 0.48, 95 % CI 0.24–0.95) when compared with 
those with CRP in the lowest quartile. There were no associations of CRP values 
with farming-related environmental factors.  
When faecal calprotectin levels were used as a marker of intestinal inflammation, 
the children who had very high calprotectin levels at the age of two months (in the 
90th percentile) had an increased risk of developing atopic dermatitis (aOR 2.02, 95 % 
CI 1.06–3.85) and asthma/asthmatic bronchitis (aOR 2.41, 95 % CI 1.25–4.64) by 
the age of six years when compared to the children who had calprotectin levels 
below the 90th percentile. 
Major moisture damage in the child’s main living areas was associated with high 
levels of CRP, enhanced interleukin (IL)-1β response in phorbol 12-myristate 13-
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acetate and ionomycin (PI) stimulated whole blood and increased secretion of 
combined levels of IL-1β, tumor necrosis factor (TNF)-α and IL-6 cytokines in 
lipopolysaccharide (LPS) stimulated whole blood at the age of six years. Also mould 
in the bathroom showed similar associations.  
In conclusion, the results suggest that increased CRP may protect from atopic 
deviation among non-atopic children. In the present study farming environment did 
not significantly induce systemic low-grade inflammation but associations were 
observed with moisture damage in home. In contrast to the low-grade inflammation, 
a high degree of intestinal inflammation during the first months of life increased the 
risk of asthma and atopic dermatitis, which indicates a long term effect of early 
changes in the gut immune system on the development of allergic diseases. Taken 
together, the results support the importance of systemic low-grade inflammation in 
the development of allergic diseases. 
 
 
 
Keywords: Asthma, atopic dermatitis, atopy, calprotectin, children, cohort, CRP, 
cytokines, environmental factors, exposure, IL-1β, IL-6, inflammation, low-grade 
inflammation, TNF-α, specific IgE 
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Tiivistelmä 
Kirsi Mustonen, The role of inflammation and its environmental triggers in allergic 
diseases [Tulehduksen merkitys ja ympäristötekijöiden aiheuttamana tulehdus 
allergisten sairauksien kehittymisessä]. Terveyden ja hyvinvoinnin laitos. Tutkimus 
140. 258 sivua. Kuopio, Finland 2014. 
ISBN 978-952-302-324-6 (painettu); ISBN 978-952-302-325-3 (verkkojulkaisu) 
 
Elimistön matala-asteinen tulehdus, joka tyypillisesti määritellään kohonneeksi C-
reaktiiviseksi proteiinipitoisuudeksi (CRP) joka on kuitenkin matalampi kuin 
infektiotaudeissa, on yhdistetty immuunivälitteisiin sairauksiin, mutta myös muihin 
kroonisiin sairauksiin, kuten valtimokovettumatautiin, metaboliseen oireyhtymään, 
liikalihavuuteen ja astmaan.  Matala-asteinen tulehdus voi toisaalta olla myös 
hyödyllinen ja edistää terveen immuunijärjestelmän kehittymistä, kuten on esitetty 
aikaisemmissa tutkimuksissa, joissa on osoitettu, että matala-asteinen tulehdus voi 
suojata allergisilta sairauksilta. Aikaisemmissa tutkimuksissa on ehdotettu, että 
maatilaympäristö suojaa atopialta ja allergisilta sairauksilta varhaislapsuudessa 
mutta mekanismit suojaavan vaikutuksen takana ovat yhä tuntemattomia. 
Mikrobialtistus ympäristössämme, kuten esimerkiksi ei-patogeeniset mikrobit 
maatilaympäristössä, voivat aiheuttaa matala-asteista tulehdusta. Toisaalta 
kosteusvauriot ja home on yhdistetty haitallisiin terveysvaikutuksiin, mutta näitä 
välittävät tekijät ovat yhä löytämättä.  
Tämän väitöskirjan tarkoituksena oli tutkia onko elimistön matala-asteisella 
tulehduksella yhteyttä allergisten sairauksien syntyyn lapsuudessa ja voivatko 
ympäristöaltisteet aiheuttaa elimistön matala-asteista tulehdusta lapsilla. Myös muita 
tulehduksen merkkiaineita tutkittiin. 
Tutkimus perustui kahteen syntymäkohorttiin: kansainväliseen PASTURE- 
tutkimukseen ja suomalaiseen LUKAS-tutkimukseen. Tulehduksen merkkiaineet 
kerättiin veri- tai ulostenäytteillä kahden kuukauden, yhden, 4,5 ja kuuden vuoden 
iässä. Aineisto lasten terveydentilasta, sekoittavista tekijöistä ja ympäristön mikrobi- 
ja maatila-altisteista kerättiin kyselylomakkeilla kuuden ikävuoden aikana.  
Kun lapsella ei ollut atopiaa yhden vuoden iässä, atopian riski 4,5 vuoden iässä 
oli pienempi lapsilla, joilla CRP-pitoisuus oli korkeimmassa neljänneksessä (vOR 
0.48, 95 % LV 0.24–0.95), kuin niillä, joilla CRP-pitoisuus oli matalimmassa 
neljänneksessä. CRP-tasoilla ja maatila-altistukseen liitetyillä ympäristöaltisteilla ei 
ollut tilastollisesti merkitsevää yhteyttä.  
Kun ulosteen kalprotektiinitasoja käytettiin suoliston tulehduksen osoittajana, 
havaittiin että lapsilla, joilla oli korkea kalprotektiinipitoisuus (korkeampi kuin 90. 
prosenttipiste) oli lisääntynyt riski sairastua kuuteen ikävuoteen mennessä 
atooppisen ihottumaan (vOR 2.02, 95 % LV 1.06–3.85) ja astmaan/ahtauttavaan 
keuhkoputkentulehdukseen (vOR 2.41, 95 % LV 1.25–4.64) verrattuna lapsiin, 
joiden kalprotektiinipitoisuudet olivat alle 90. prosenttipisteen. 
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Merkittävä kosteusvaurio lapsen pääasiallisissa asuintiloissa oli yhteydessä 
korkeisiin CRP-pitoisuuksiin, lisääntyneeseen interleukiini (IL)-1β vasteeseen PI-
stimuloidussa veressä ja lisääntyneeseen IL-1β, tuumorinekroositekijä (TNF)-α ja 
IL-6 sytokiinien yhdistelmämuuttujan pitoisuuksiin LPS-stimuloidussa veressä 
kuuden vuoden iässä. Myös kylpyhuoneen homeella oli vastaavia yhteyksiä 
sytokiinipitoisuuksien kanssa. 
Tutkimustulokset viittaavat siihen, että koholla oleva CRP-pitoisuus voi suojata 
atopialta ei-atooppisilla lapsilla. Tässä tutkimuksessa maatilaympäristö ei 
aiheuttanut elimistön matala-asteista tulehdusta merkittävästi, mutta matala-asteinen 
tulehdus oli yhteydessä kodissa todettuun kosteusvaurioon. Sitä vastoin korkea-
asteinen suolistotulehdus ensimmäisten elinkuukausien aikana lisäsi riskiä sairastua 
astmaan ja atooppiseen ihottumaan, mikä viittaa siihen että varhaisilla muutoksilla 
suolen immuunijärjestelmässä on pitkäkestoisia vaikutuksia allergisten sairauksien 
kehittymisessä. Yhteenvetona voidaan todeta, että tulokset tukevat käsitystä 
elimistön matala-asteisen tulehduksen tärkeästä merkityksestä allergisten sairauksien 
kehityksessä. 
 
Avainsanat: Altiste, astma, atooppinen ihottuma, atopia, CRP, IL-1β, IL-6, 
kalprotektiini, kohortti, lapset, matala-asteinen tulehdus, sytokiinit, spesifinen IgE, 
TNF-α, tulehdus, ympäristötekijät 
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1 INTRODUCTION 
Inflammation is a key feature in many diseases such as cardiometabolic diseases 
(Emerging Risk Factors Collaboration 2012, Zhu et al. 2000) and chronic 
noncommunicable diseases such as autoimmune diseases and asthma (Kim et al. 
2011, Prescott 2013). It is possible that some chronic inflammatory diseases may be 
due to dysfunctions in the regulation of the inflammatory response (Naik and Wala 
2013). On the other hand, it has been suggested that low-grade inflammation may 
protect individuals from allergic diseases (Marschan et al. 2008, Viljanen et al. 
2005). 
The hygiene hypothesis was introduced in 1989. The original hypothesis claimed 
that the increase in the prevalence of allergic diseases during childhood might be 
due to declining family sizes, improvement in household amenities and higher 
standards of personal cleanliness, leading to fewer incidents of clinical and 
subclinical infections (Strachan 1989). Later, the focus of the hygiene hypothesis 
has been shifted towards contact with non-pathogenic microbes in early life rather 
than clinical infections (Martinez 2001). 
There are different microbial agents in our environment that can cause 
systemically or locally measurable inflammation, e.g. microbes in the farming 
environment, which has been shown to protect from allergic diseases (Ege et al. 
2011). Also the microbiota of the gastrointestinal tract is an important regulator of 
inflammation and immune responses. Gut immune system is a major part of the 
immune system. It has been newly discovered that disturbances in gut microbiota 
are associated with the development of allergic diseases (West 2014). On the other 
hand, moisture damage or mould in buildings can cause asthma (Cox-Ganser et al. 
2009, Jaakkola et al. 2005, Park et al. 2008, Pekkanen et al. 2007).  
Mechanisms behind inflammatory responses and the nature of the inflammation 
induced by these different microbial and other stimuli are still unknown and more 
research is needed to understand these associations. There might also be exposures 
which cause downregulation of inflammation and thus cause health effects. 
In addition, there is limited amount of information on the role of inflammation 
and the environmental exposures causing inflammation in the development of 
allergic diseases in children.  
 
 
 
 
THL — Research 140 • 2014 16 
The role of inflammation and its 
environmental triggers in 
allergic diseases 
 
2 REVIEW OF THE 
LITERATURE 
2.1 Inflammation  
The innate immune system deals infections, tissue injuries or stress by stimulating 
local and/or systemic inflammation (Medzhitov 2008). Inflammation is a process 
characterized by the recruitment of leucocytes and plasma proteins from the blood 
into tissues where the inflammatory response is activated, in order to defend the host 
against infections, repair tissue and adapt to stress and restore a homeostatic state 
(Medzhitov 2008). A persistent or aberrant dysregulated inflammation tends to 
initiate tissue destruction rather than tissue restoration. 
Several factors are involved in an inflammatory process: cellular components 
(mast cells, eosinophils, basophils, lymphocytes, dendritic cells), inflammatory 
mediators (cytokines, chemokines, lipid mediators), and structural cells (epithelial 
cells, airway smooth muscle cells, keratinocytes, endothelial cells, mucus-secreting 
cells). The nature of the inflammatory response is determined by the profile of the 
inflammatory mediators and cellular components involved. As an example, the 
secretion of interleukin (IL) -4, IL-5, IL-9 and IL-13 cytokines by T-helper 2 (Th2) 
lymphocytes and proinflammatory IL-1β, IL-6, tumor necrosis factor-α (TNF-α) and 
granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokines secreted by 
a variety of cells are the key factors mediating inflammation in allergic reactions 
(Barnes 2011).  
C-reactive protein (CRP) is a marker of systemic inflammation in the plasma 
produced by liver after the stimulation of cytokines IL-6, IL-1β and TNF-α which 
are produced by dendritic cells, macrophages and other types of cells of the innate 
immune system. CRP binds to several different species of bacteria, fungi and 
parasites and CRP recognizes molecular ligands found on bacterial membranes and 
on apoptotic cells, such as phosphorylcholine and phosphatidylethanolamine (Pepys 
and Hirschfield 2003). CRP activates the classical complement pathway by binding 
a plasma protein called C1q. Elevated levels of CRP are seen in several allergic and 
non-allergic conditions (Bottazzi et al. 2010, Deraz et al. 2012, Lopresti et al. 2014, 
Rhodes et al. 2011, Vermeire et al. 2004). The plasma concentrations of CRP are 
very low in healthy individuals and therefore in the clinic CRP is mainly used as a 
marker of acute infection and during such CRP level can increase up to 1000-fold 
(Pepys and Hirschfield 2003). 
In recent years, inflammatory mediators have been studied as potential markers 
of more subtle and chronic systemic inflammatory state that is called low-grade 
inflammation (Medzhitov 2008). In this thesis a low-grade inflammation is defined 
REVIEW OF THE LITERATURE 
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as subclinical systemic inflammation characterised by the increased production of 
acute-phase proteins (CRP) below the levels seen in clinical infections.  
One of the earliest responses of the innate immune system to any stimulation is 
the secretion of cytokines by tissue cells, which is crucial for the acute inflammatory 
response. The three most important proinflammatory cytokines IL-1β, IL-6 and 
TNF-α have systemic effects and are responsible for many clinical signs of infection 
and inflammatory disease. In this study, IL-1β, IL-6, TNF-α, number of leucocytes 
and exhaled nitric oxide are used as a way of measuring inflammatory processes 
(Kharitonov and Barnes 2001, Sabato et al. 2006, Schroder and Tschopp 2010, Sims 
and Smith 2010). 
Noncommunicable inflammatory or immune-mediated diseases, including 
allergic diseases, have drastically increased over the last few decades. Chronic 
inflammation is a common factor of these diseases, indicating the central role of the 
immune system (Renz et al. 2011). Many environmental factors, such as dietary 
factors (Dunstan et al. 2003, Field et al. 2010), maternal smoking during pregnancy 
(Noakes et al. 2003), environmental pollutants (Liu et al. 2008), microbial patterns 
(Prescott 2011) and stress (Mattes et al. 2009) have been shown to be able to affect 
the cytokine levels and thus are able to cause changes in the immune system and 
affect inflammatory processes in humans, even in children in utero. Thus, it has been 
suggested that dysregulation of inflammation, partly due to environmental effects, 
leads to the onset of noncommunicable diseases, including asthma and allergies 
(Prescott 2013).  
It has been shown that low-grade inflammation is a relevant and an independent 
predictor of coronary heart diseases (Danesh et al. 2000, Willerson and Ridker 2004) 
and strongly related to obesity and type 2 diabetes (Pickup 2004, Sjoholm and 
Nystrom 2005). In obesity, inflammation of the fat tissue is considered as one of the 
causes of increased CRP levels. High levels of CRP in adolescence predicted the 
metabolic syndrome in adulthood (Mattsson et al. 2008) suggesting that low-grade 
inflammation may predict adverse health effects. 
Although low-grade inflammation may be involved in pathogenesis and 
exacerbation of many diseases, it has also been hypothesised that low-grade 
inflammation might predict a decreased risk of allergic diseases (Marschan et al. 
2008, Viljanen et al. 2005).  This has been explained by the beneficial effects of 
microbial exposure to the maturation of the immune system according to the 
principals of the hygiene hypothesis and in this model CRP is a marker of microbial 
load. 
In contrast, the up-regulation of the inflammatory mediators has been seen in 
subjects exposed to moisture damage and related microbial load (Punsmann et al. 
2013a). Altogether, the role of inflammation and the nature of the inflammatory 
response in the development of allergic diseases appears to be crucial but the present 
knowledge of these factors is still limited and thus the interpretation of the studies 
on inflammation in allergic diseases is challenging.  
REVIEW OF THE LITERATURE 
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2.2 Definitions and risk factors of allergic diseases 
2.2.1 Definitions of atopy, asthma and atopic dermatitis 
Atopy is defined by an individual’s capacity to produce a specific IgE antibody 
responses or a positive skin prick reaction to common environmental or food protein 
antigens (Johansson et al. 2004).  Atopic people have a greater tendency to develop 
typical symptoms of allergic diseases such as asthma, rhinoconjunctivitis or 
dermatitis (Johansson et al. 2004).  
According to Global Initiative for Asthma report (GINA 2012), asthma is defined 
as a chronic inflammatory disease of the airways and lungs which are obstructive 
due to bronchoconstriction, mucus plugs and inflammation. Symptoms of asthma are 
recurring episodes of wheezing, breathlessness, chest tightness and coughing, 
especially at night or early in the morning. Due the several phenotypes the 
characterisation of different asthma is challenging (GINA 2012). There have been 
identified at least six different wheezing phenotypes in children: never wheeze, early 
transient wheeze, prolonged early wheeze, intermediate-onset wheeze, late-onset 
wheeze and persistent wheeze (Henderson et al. 2008, Martinez et al. 1995). Asthma 
is difficult to define as a single disease and therefore there is no consistent 
classification for asthma phenotypes. 
Atopic dermatitis (AD, atopic eczema) is an inflammatory, relapsing and pruritic 
skin disease which occurs usually among families with atopic diseases and affects 
especially infants and small children (Darsow et al. 2010). AD is a non-contagious 
inflammation of epidermis and dermis and its characteristic clinical signs are itch, 
erythema, papule, seropapule, vesicle, squames, crusts, lichenification, in 
synchronous or metachronous polymorphy and dermatopathological signs are 
spongiosis, acanthosis, hyper- and parakeratosis, lymphocytic infiltrates and 
exocytosis and eosinophils (Bieber 2010, Darsow et al. 2010). AD is associated with 
asthma and allergic rhinitis and patients with AD often have allergic symptoms to 
various food and inhalant allergens (Hon et al. 2008, Ponyai et al. 2008). 
Atopy has shown to be strongly associated with AD (Leung 1995). Atopy does 
not imply that a person has an allergy, but the risk for develop allergies is increased 
among atopics. On the other hand, asthma and atopy are not that strongly correlated. 
It has been reviewed that less than a half of the asthmatics are attributable to atopic 
sensitisation (Pearce et al. 1999). A systematic review showed that on average, one 
of three young children with AD develops asthma later during his/her childhood 
(van der Hulst et al. 2007). Atopic dermatitis is dependent on the Th1/Th2 
lymphocyte imbalance, with a tendency to produce IgE (Bieber 2010) and the risk of 
food allergy, asthma and allergic rhinitis is defined as ‘the atopic march’ (Dharmage 
et al. 2013).  
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2.2.2 Hygiene hypothesis and allergic diseases 
David Strachan postulated the hygiene hypothesis in 1989, and suggested that 
infectious agents might protect us from allergic disease (Strachan 1989). The 
hygiene hypothesis suggests that frequent confrontation with proinflammatory 
microbial agents in childhood induces the maturation of Th1-immunity and 
downregulation of Th2 immune response which might protect from allergy prone 
reactions. The original observation was that the risk of hay fever decreased with the 
increasing number of siblings (Strachan 1989).  
It has later been reviewed that these original observations explain only part of the 
story (Fuleihan 2002, Kumar 2008) and the focus of the hypothesis has shifted since. 
The present knowledge is that not the clinical infections but the lack of appropriate 
immune stimulation during early childhood with the consequence of disturbed 
alignment in the encountering antigens and microbes might account in the rise of 
allergic diseases (Martinez 2001). Moreover, the pregnant mother’s exposure to 
farm-related microbial agents, which cause the production of cytokines and 
regulatory T cells and expression of Toll-like receptors, has been hypothesised to 
provide immunotherapy to the child and thus protects the child from allergic 
diseases later (Eder et al. 2006, Pfefferle et al. 2010, Schaub et al. 2009, von Mutius 
and Vercelli 2010).  
The risk of asthma is inversely correlated with increasing diversity of bacterial 
and fungal taxa in home-dust samples (Ege et al. 2011). In addition altered microbial 
flora in the gut is associated with food allergy (Rodriguez et al. 2011), whereas 
colonisation in the neonatal gut by certain bacterial species is thought to be 
protective against the development of asthma (Vael et al. 2011). 
Varicella zoster infection has been shown to associate with the protection against 
eczema (Silverberg et al. 2010) supporting the view that some infections might 
protect from allergic diseases. Several studies have shown the relationship between 
bacterial/viral infection and asthma but it is still unknown whether infections are risk 
factors for developing asthma (Callaway and Kim 2011, Fuchs and von Mutius 2013, 
Sly et al. 2010). Children with asthma may be more sensitive to viral and bacterial 
infections due to impaired mucosal and systemic immune responses (Fuchs and von 
Mutius 2013). Furthermore, previous infections seem to shape the immune system	  as 
compared with more recent illnesses (Yang and Gao 2011). 
The mechanisms that protect from the development of allergic diseases include 
effects on the innate immune system, development of regulatory T cells and Th1 
skewing. Also, the gene–environment interaction is crucial in predisposing to 
allergic diseases. It is not likely that there is one specific cause as the trigger for 
allergic diseases, and even more unlikely that one specific infection can prevent or 
cause atopy (Fishbein and Fuleihan 2012). 
Regardless of whether the environmental microbes are primarily exposed to the 
respiratory, the gastrointestinal or the skin mucosal surface, these microorganisms 
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may closely interact with the epithelial barrier and the innate immune system. It has 
recently been shown that these barrier microbes play a pivotal role in shaping 
immune responses, particularly early in life. These microbes apparently play a 
decisive role in either generating (mucosal) tolerance or leading up to the 
development of allergic diseases (Shreiner et al. 2008). 
2.2.3 Other risk factors of atopy, asthma and atopic dermatitis 
2.2.3.1 Atopy 
The complex interactions between genetic predisposition and environmental 
exposures are the factors that mainly determine whether a child develops atopy 
(Wright 2004). Maternal history of atopy is the strongest risk factor for the 
development of atopy (Liu et al. 2003, Ruiz et al. 1992). Maternal atopy and 
infections during pregnancy may act as immunomodulators in the development of 
atopy, but it is unknown whether these factors can enhance or inhibit the 
development of atopy (Illi et al. 2014).  Moreover, exposure to allergens in utero 
may influence the capability of the infant to respond immunologically to allergen 
exposure (Hagendorens et al. 2004, Miller et al. 2001, Peters et al. 2009). 
2.2.3.2 Asthma 
Both environmental stimuli and genetic predisposition contribute to the development 
of asthma (Murphy and O'Byrne 2010). Various stimuli, such as chemokines, 
cytokines and lipid mediators can cause membrane fibrosis, smooth muscle 
hyperplasia, new vessel formation and glandular hyperplasia that are referred to as 
airway remodeling and lung inflammation and largely contribute to asthma 
pathogenesis (Naik and Wala 2013).  
In addition to familiar disposition, passive or active smoking seems to be the 
most consistent risk factor for asthma. It is shown that parental smoking is 
associated with wheezing in early life and with wheezing and asthma in childhood 
(Strachan and Cook 1998). Active smoking is also shown to be associated with the 
onset of asthma in adolescents and adults (Larsson 1995, Strachan et al. 1996). In 
addition, maternal home second-hand smoke exposure during pregnancy is 
associated with childhood asthma, even if the mother herself does not smoke 
actively during pregnancy (Simons et al. 2014). 
Exposure to outdoor air pollution has been shown to associate with an increase in 
asthma symptoms and health care use (Tatum and Shapiro 2005). However, it is still 
uncertain whether pollutants, such as ozone and particulate matter, contribute to the 
development of asthma (Eder et al. 2006). 
Exposure to environmental allergens has controversial effects on the 
development of asthma.  There is evidence that exposure to pets, especially to dogs, 
perinatally and at an early age protects persons from asthma (Lodge et al. 2012). 
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Furthermore, early atopic sensitisation to inhalant allergens and food allergy are risk 
factors for developing asthma (Guilbert et al. 2004). 
Dampness and mould in buildings have been stated to cause adverse respiratory 
symptoms, including asthma (Cox-Ganser et al. 2009, Jaakkola et al. 2005, Park et 
al. 2008, Pekkanen et al. 2007). There is however no consensus on what are the 
organisms and compounds which cause the adverse effects are and through which 
mechanisms they work. In addition obesity from infants to young adults predicts 
increased incidences of asthma diagnosis or symptoms in the future, especially for 
girls (Liu et al. 2013). There is also some weak evidence that deficiencies of the 
nutrients, such as vitamins A, D and E, zinc, fruit and vegetables may be associated 
with the development of asthma (Nurmatov et al. 2011). 
2.2.3.3 Atopic dermatitis 
It seems that a defect in the cutaneous barrier function is an important factor for the 
development of AD. This view is supported by studies showing abnormalities in 
filaggrin and in the proteins of the epidermic differentiation complex (Hoffjan and 
Stemmler 2007). Also dysfunction of the innate and/or adaptive immune response is 
seen in AD (Eyerich and Novak 2013). The pathogenesis of the disease is not fully 
understood. 
The etiology is multifactorial and different types of genetic predisposition and 
environmental factors, such as mutations of filaggrin gene, the exposure to allergens 
and the expression of thymic stromal lymphopoietin, have been suggested to be 
involved in the initiation of the disease (Baurecht et al. 2007, Capristo et al. 2004, 
Wilson et al. 2013).  
Risk factors for AD are family’s higher socioeconomic status (DaVeiga 2012), 
family’s higher level of education (DaVeiga 2012, Harris et al. 2001), a smaller 
family size (DaVeiga 2012, Harris et al. 2001), urban environment (Schram et al. 
2010), “Western” diet (Ellwood et al. 2013), broad-spectrum antibiotic exposure 
(Schmitt et al. 2010) and reduced diversity in the bacterial gut flora (Wang et al. 
2008). Environmental factors such as climate, outdoor air pollution and tobacco 
smoke, have been studied but the relationship between these factors and atopic 
dermatitis are complex (Flohr and Mann 2014). 
2.3 Farming, immune system and allergic diseases 
2.3.1 Farming and allergic diseases 
Among adults, there is evidence that large animal feeding operations, organic dusts 
and bacteria in farming environments cause upper and lower respiratory tract 
disorders, including asthma (Charavaryamath and Singh 2006, Malmberg et al. 
1993, May et al. 2012).  
In contrast, since over a decade, numerous studies have shown evidence that 
farming environment in childhood protects children from atopy, allergic diseases 
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and asthma (Braun-Fahrlander et al. 1999, Downs et al. 2001, Leynaert et al. 2001, 
Remes et al. 2003, Riedler et al. 2001, Von Ehrenstein et al. 2000). First it seemed 
that the protective effect was mainly against atopy and only partly against asthma 
(Naleway 2004). Later, systematic meta-analysis concluded that the prevalence of 
asthma may be 25 % lower in the children who live in farming environments 
(Genuneit 2012). The estimated relative risk of atopy among farm-living children 
has been stated to be 41 % lower than among nonfarm-living children (Perkin and 
Strachan 2006). However, there is no consistent evidence that farming environment 
during childhood protects from the development of AD and the estimated risk for 
AD is 0.97 (Perkin and Strachan 2006). It has been difficult to find consensus on the 
protective farm effect due to the different phenotypes of asthma and allergic diseases 
(Fuchs et al. 2012).  
The protection from the diseases is strongest if the exposure to farms occurs in 
utero or during the early years of life (Illi et al. 2012, Riedler et al. 2001). However, 
farms and farming environments are not homogenous and thus diverse exposures are 
characteristic for the farm effect. In addition, it has been shown that different 
exposures protect individuals from distinct diseases, not from all atopic or allergic 
diseases (Ege et al. 2007, Illi et al. 2012). Protective effects for atopy have been 
identified to be agriculture, pig and poultry farming and barns, whereas agriculture, 
pig farming, silage, haying, farm milk, animal sheds and barns have been identified 
to protect individuals from asthma (Ege et al. 2007). 
After the findings of the protective farm effect, it has been intensively 
investigated what the protective exposures on the farms are. Identified exposures 
that have been contributed to the reduced risk of asthma and allergies in farm 
children are contact with cattle, pigs and poultry, contact with hay, grain, straw and 
silage and the consumption of unprocessed cow milk (Douwes et al. 2008, Ege et al. 
2007, Riedler et al. 2000, Riedler et al. 2001, Von Ehrenstein et al. 2000). Other 
farm-related lifestyle factors such as duration of breast feeding, family size, daycare 
attendance, other dietary factors or parental education were not decisive factors for 
the protective farm effect (von Mutius and Vercelli 2010). 
Farmers have been reported to own more pets than non-farmers and there is 
reviewed evidence of the protective pet ownership (Naleway 2004). However, the 
protective effect may only occur during early life and later on it may actually worsen 
the symptoms in children who already have asthma or allergic disease (Johnson and 
Alford 2002, Wickens et al. 2002). The farms with livestock have been reviewed to 
protect individuals from asthma and allergic disease (Naleway 2004). The farm 
animal effect seems to be rather strong and the protective effect of early life 
livestock contact against atopy, asthma and atopic dermatitis has been shown to 
remain until adulthood (Lampi et al. 2011). 
It has been recently reviewed that a pregnant mother’s and a child’s exposure to 
cows and straw on farms and the consumption of farm milk are identified as 
protectors from asthma but the protection from atopy seems to be less significant 
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(Illi et al. 2012, Wlasiuk and Vercelli 2012). Furthermore, these three exposures 
have been described to be responsible for the overall farm effect considering asthma 
(Illi et al. 2012). On the other hand, staying in a fodder storage room (Illi et al. 2012), 
helping with haying (Karadag et al. 2007) and maternal contact with farm animals 
and cats during pregnancy (Roduit et al. 2011) proved to be protective factors 
against atopic dermatitis. High microbial diversity in the farm environment is 
reported to protect from asthma but its association with atopy seems to be less 
significant (Ege et al. 2011, Wlasiuk and Vercelli 2012).  
Farm milk consumption is one of the most discussed farming exposures. There is 
reviewed evidence that the consumption of raw cow milk protects from the 
development of asthma and allergic diseases (Braun-Fahrlander and von Mutius 
2011). It has also been reviewed that maternal consumption of unprocessed cow 
milk protects from the development of childhood asthma and atopy (von Mutius 
2012). However, raw milk contains different pathogens which can cause severe 
infections and thus it can not be recommended as a preventive agent against allergic 
diseases (Braun-Fahrlander and von Mutius 2011, von Mutius 2012).  
Also, in Finland farming environment in childhood, especially contact with cattle, 
reduces the occurrence of asthma and atopy in children (Remes et al. 2005) and in 
adults (Lampi et al. 2011), but the consumption of farm milk was not associated 
with the reduced risk of atopy and allergic diseases (Remes et al. 2003). 
In conclusion, the main protective farming exposures against allergic diseases 
could be livestock contact, farm milk consumption and early contact to cats and 
dogs. 
2.3.2 Farming environment and its effects on the immune system 
Earlier studies suggested that microbial markers such as endotoxin 
(lipopolysaccharides, LPS), muramic acid and beta-glucans are responsible for the 
protective effect of the farm exposure on asthma and allergic diseases and there is 
evidence that these factors are at least partly involved (Braun-Fahrlander et al. 2002, 
Karadag et al. 2007, Schram-Bijkerk et al. 2005, van Strien et al. 2004). Bacterial 
components engage with antigen-presenting cells eliciting cytokine inducing 
response (Braun-Fahrlander 2003). It has been shown that endotoxin levels in home 
correlated with interferon gamma (IFN-ɣ) T-helper type 1 cells but not with IL-4, 
IL-5 or IL-13 producing T-helper type 2 cells in infants (Braun-Fahrlander 2003, 
Braun-Fahrlander et al. 2002, Gereda et al. 2000). In addition, another study showed 
that IFN-ɣ producing capacity during first months of life was positively associated 
with endotoxin levels in house dust (Roponen et al. 2005). On the other hand, 
among school age children greater endotoxin exposure was associated with the 
reduced production of TNF-α, IL-10, IL-12 and IFN-ɣ cytokines (Braun-Fahrlander 
et al. 2002). One interpretation is that endotoxin exposure may enhance Th1 
immunity (Gereda et al. 2000). On the other hand, endotoxin exposure can suppress 
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the cytokine production and the phenomenon is called LPS tolerance and 
furthermore LPS tolerance may contribute to the protective effect of a farming 
environment (Stiehm et al. 2013, West and Heagy 2002).  
Low IFN-ɣ expression levels at birth have been shown to associate with an 
increased risk for the later development of allergic symptoms and atopic disease and 
furthermore low IFN-ɣ in the first year of life is known to be a strong predictor of 
airway obstruction during childhood (Stern et al. 2007, Vuillermin et al. 2009, 
Wright 2004). 
Pathogens and damage-associated molecules are recognized by pattern 
recognition receptors (PRR) of the toll-like receptor (TLR) -family, which are the 
major triggers of the innate immunity response. Farmers’ children blood cells 
expressed higher amounts of CD14 and TLR2 than non-farmers’ (Lauener et al. 
2002). Furthermore, the higher the number of different farm animal species the 
pregnant mother had contacted, the higher the levels of TLR2, TLR4 and CD14 
were at school age (Ege et al. 2006). These studies indicated that the exposure to the 
ample microbial environment on farms produces an upregulation of innate immunity 
receptors (von Mutius and Vercelli 2010). Furthermore, enhanced expression of 
genes interleukin-1 receptor-associated kinase 4 (IRAK-4) and receptor (TNFRSF)-
interacting serine-threonine kinase 1 (RIPK1) of innate immunity and enhanced 
expression of IL-10, transforming growth factor beta  (TGF-β), suppressor of 
cytokine signaling 4 (SOCS4) and IRAK-2 regulatory molecules have been found in 
farmers’ school-aged children suggesting that these factors contribute to the 
mechanisms of the hygiene hypothesis (Frei et al. 2014). 
Many studies have tried to identify specific bacteria and fungi from dust samples 
taken from children’s mattresses on farms. No specific protective microbes have 
been characterised but there is evidence that higher microbial diversity is inversely 
associated with asthma (Ege et al. 2011, Normand et al. 2011).   
The protective effect of farm milk has been tried to be explained by its 
concentration of pathogenic bacteria and whey proteins (Lluis and Schaub 2012). 
However, bacterial endotoxin has not been detected to be the protective agent in 
farm milk (Gehring et al. 2008). It has been newly discovered that farm milk 
exposure was associated with increased number of regulatory T cells (Tregs) in 
children and Tregs were inversely associated with asthma and atopy (Lluis et al. 
2013). The authors suggest that Tregs play a major role by transmitting the 
protective effect of farm milk consumption (Lluis et al. 2013). 
There are a limited number of studies reporting the association between 
environmental microbial exposure and stimulated peripheral blood cytokine 
production. One study has shown that Gram-positive and negative bacteria, 
measured from house dust, were associated with stimulated peripheral blood 
cytokine production in the mothers of the study (Lappalainen et al. 2008). Gram-
negative bacteria were associated with the down regulation of proinflammatory 
cytokines (TNF-α and IL-6) and Gram-positive bacteria had the opposite effect 
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(Lappalainen et al. 2008). In addition, high level of Gram-positive bacteria or 
Mycobacterium species in house dust was associated with decrease IFN-ɣ 
production at the age of one year (Lappalainen et al. 2012). 
It has been shown that pig farmers had higher levels of circulating neutrophils, 
IL-13 and IL-4 (Th2 responses) cytokine concentrations compared to the control 
subjects (Sahlander et al. 2010) and this study suggests that after the exposure to 
organic dust there might be a systemic inflammatory response. A similar response 
was also seen among smokers and the researchers suggest that this phenomenon is 
related to adverse respiratory disorders in these groups (Sahlander et al. 2010). It has 
also been shown that occupational exposure to farm animals associated with serum 
IL-8, IL-10 and TNF-α responses compared to non-exposed controls (Tabibi et al. 
2012). These studies show that farming environment may influence 
proinflammatory cytokine production during adulthood. 
It has been recently reviewed that the exposure to the organic dust modulates 
innate immunity, involving toll-like receptors and nucleotide oligomerization 
domain 2 (NOD2) mediating inflammatory consequences, and these alterations 
might protect from allergic response (Poole and Romberger 2012). Furthermore, 
there is evidence that farming exposure can affect innate immunity in children 
(Poole and Romberger 2012). 
Moreover, a model of the immunobiology of farming has been presented (von 
Mutius and Vercelli 2010).   In this model, different key effector mechanisms of 
allergic diseases are inhibited by the immunoregulatory characteristic of farm-
related microbial exposures. Contact with several animal species and consumption 
of farm milk together, results in strong microbial exposure of women living on a 
farm during pregnancy. Authors conclude that these exposures, occuring at a time 
when immune responses are programmed, affect regulatory T cells and cytokine 
production at birth, which enhance innate immune responses, and suppress T-helper 
2 cell-dependent allergic inflammation in early childhood (von Mutius and Vercelli 
2010).  
There is, however, still a limited number of studies concerning which 
environmental farming factors are capable of inducing inflammation in humans and 
what the best markers to detect such inflammation are. Moreover, it is still unsolved 
whether the induced inflammation is capable of protecting individuals from allergic 
diseases. 
2.4 Moisture damage, inflammation, allergic diseases 
2.4.1 Moisture damage and allergic diseases 
It has been concluded that moisture damage, mould problems and dampness in 
buildings cause adverse health effects in humans (Institute of Medicine (IOM) 2004, 
World Health Organization 2009). The strongest evidence of adverse health effects 
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of moisture damage, mould or dampness are for respiratory symptoms such as 
wheezing, cough and asthma exacerbation (Bornehag et al. 2001, Bornehag et al. 
2004). There are limited amount of studies that have showed the relationship 
between moisture damage and mould and the development of new asthma but few 
studies have shown the positive association (Cox-Ganser et al. 2009, Jaakkola et al. 
2005, Park et al. 2008, Pekkanen et al. 2007). Later on, the WHO has stated that 
there is an association between moisture damage and mould in buildings and the 
development of asthma in children (World Health Organization 2009). In addition, a 
recent meta-analysis of 16 studies concluded that dampness and mould in the home 
are determinants of developing asthma (Quansah et al. 2012). There is also some 
evidence of the association between dampness or mould and allergic rhinitis, eczema 
and atopy (Mendell et al. 2011).  
Suggested exposures behind the adverse health effects in buildings with moisture 
damage, mould or dampness, are micro-organisms or their fragments, toxins, 
allergens, other volatile organic compounds (World Health Organization 2009) or 
non-biologic emissions such as formaldehyde and 2-ethyl-1-hexanol (Mendell et al. 
2011). Despite a large number of studies investigating moisture damage, mould or 
dampness, the mechanisms or causal relations of the adverse health effects are still 
unknown. 
There is a large number of fungal and bacterial species that have been isolated 
from moisture damaged buildings (Andersson et al. 1997, Samson et al. 1994) but 
the species that cause the adverse health effects have not been identified yet. Many 
factors, such as the diversity and quantity of species, relations between different 
microbes, severity of the moisture, temperature, relative humidity, air flows and 
pressure and availability of nutrients, influence the conditions of the microbial 
growth and the microbes’ capability to produce toxins or microbial volatile 
compounds. 
It has been reported that in moisture damaged schools there is a larger amount of 
microbial metabolites than in schools without moisture damage (Peitzsch et al. 
2012). For example the mycotoxins, likely to originate from indoor fungal growth, 
were found in the moisture damaged schools in Finland (Peitzsch et al. 2012). 
Furthermore, it has been shown that in moisture damaged homes bacterial 
compounds monactin, nonactin, staurosporin and valinomycin were detected in 
building materials from moist structures (Taubel et al. 2011). These compounds are 
produced by Streptomyces species which is one of the indicator markers of moisture 
damage indoors. These findings suggest that bacterial and fungal metabolites are a 
part of microbial exposure in moisture damaged buildings and they may be at least 
partly responsible for the observed adverse health effects. 
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2.4.2 Moisture damage and inflammation 
The associations between moisture damage or microbes originating from moisture 
damaged building and airway inflammatory responses have been studied in murine 
models and in the nasal lavage samples in humans (Hirvonen et al. 1999, Jussila et 
al. 1999, Jussila et al. 2003, Purokivi et al. 2001, Roponen et al. 2013, Stark et al. 
2006). A study showed that proinflammatory IL-1β and TNF-α cytokine levels were 
increased in nasal lavage after exposure to the indicator microbe for moisture 
damage (Stark et al. 2006). Another study showed that IL-4 concentration was lower 
and IL-6 concentration tended to be lower in the nasal lavage fluid samples of those 
subjects who were in the buildings after the renovation of the moisture damage and 
higher before the renovation (Roponen et al. 2013). Personnel who were exposed to 
a mould-contaminated school had higher levels of TNF-α, IL-6 and nitric oxide (NO) 
in their nasal lavage samples than their control subjects (Hirvonen et al. 1999). 
Furthermore, a study by Purokivi et al. (2001) showed that concentration of IL-1 
was higher in nasal lavage samples of personnel of the moisture damaged school 
compared to the subjects from the control school and concentrations of TNF-α and 
IL-6 in nasal lavage of exposed workers were significantly higher during exposure 
to the moisture damaged school than after vacation. In addition moisture damage has 
been suggested to be capable of inducing immunostimulation and systemic 
immunotoxicity in mice (Jussila et al. 2003). 
There are numerous microbes that have been found to associate with moisture 
damage but some microbes have been detected to induce cytokine production. 
Bacteria Streptomyces anulatus, Streptomyces californicus,  Bacillus cereus, 
Pseudomonas fluorescens, mycobacteria Mycobacterium avium complex and 
Mycobacterium terrae and fungi Stachybotrys chartarum and Aspergillus versicolor 
have been able to induce the production of IL-1, IL-4, IL-6 and TNF-α cytokines  
and nitric oxide in mouse and human cell line models (Hirvonen et al. 2005, 
Huttunen et al. 2001, Huttunen et al. 2003, Jussila et al. 1999, Jussila et al. 2001, 
Murtoniemi et al. 2005, Penttinen et al. 2005, Roponen et al. 2001). On the other 
hand, it has been shown that fungal spores did not cause inflammatory changes in 
nasal lavage samples among sawmill workers whose fungal spore exposure at work 
is much higher than the exposure of people to fungal spores in mould-damaged 
buildings (Roponen et al. 2002). 
In addition, particle samples, high number of viable bacteria and fungi and high 
microbial total amount from moisture damage sources have also been found to 
induce inflammatory mediators in murine models and in human nasal lavage fluid 
samples (Huttunen et al. 2008, Roponen et al. 2003). 
It has been suggested that bacterial and fungal components derived from 
moisture damage can stimulate systemic production of proinflammatory cytokines in 
humans (Beijer et al. 2003, Punsmann et al. 2013b). Furthermore, the production of 
cytokines IL-8 and IL-1β have been shown to be increased in vitro after exposure to 
REVIEW OF THE LITERATURE 
 
 
THL — Research 140 • 2014 28 
The role of inflammation and its 
environmental triggers in 
allergic diseases 
 
moisture damage or dampness (Punsmann et al. 2013a, Zhang et al. 2012). On the 
other hand, two studies found inverse association between building dampness and 
cytokine IL-6 (Sahlberg et al. 2012, Zhang et al. 2012). In addition, among humans 
who had high levels of β-(1,3)-glucan at home, the secretion of TNF-α cytokine was 
higher in vitro than among the group of individuals with low levels of β-(1,3)-glucan 
(Beijer et al. 2003). Furthermore, no significant differences were found in the 
secretion of IFN-ɣ and IL-4 levels (Beijer et al. 2003).  
There are three studies which have investigated the relationship between 
moisture damage and CRP values in humans. Purokivi and her colleagues compared 
CRP values between adults who were working in moisture damaged and control 
school buildings (Purokivi et al. 2001). A longitudinal study investigated the 
association between moisture damage or mould at workplace during ten year follow-
up and CRP values at the time of the follow-up (Zhang et al. 2012).  These studies 
showed no significant association between moisture damage or mould and CRP 
values (Purokivi et al. 2001, Zhang et al. 2012). On the other hand, another study 
from the same study cohort as Zhang et al. (2012) found a positive association 
between dampness at home at the beginning of the study and CRP values at the time 
of the follow-up (Sahlberg et al. 2012). Limited amount of reported studies between 
the association of moisture damage and CRP values makes the conclusions difficult. 
2.5 Gut inflammation and allergic diseases 
The mucosal immune system including airways, gut, conjunctiva, urinary and 
genital tracts provides a first defense line of the inner body surfaces (Brandtzaeg 
2009). There are three ways of the mucosal tissue to handle different antigens: 
initiate an immune response, ignore antigens or induce tolerance to it. Mucosal 
tolerance is systemic unresponsiveness where in the absence of proinflammatory 
signals regulatory T cells in the mesenteric lymph nodes mediate systemic antigen-
specific tolerance (Fukaya et al. 2010, Hadis et al. 2011). Mucosally induced 
tolerance to antigens probably involves also other suppressive mechanisms and 
tolerance initiation needs microbe-associated molecular signals sensed by innate 
immunity (Slack et al. 2009). 
The gastrointestinal tract contains a major part of the immune system, with 
several immunologic cellular and humoral components that defend the host against 
foreign antigens (Fouhy et al. 2012, Lozupone et al. 2012). The influence of 
ingested micro-organisms together with the host’s features modifies the gut 
microbiome and thus may influence the immune response of the host (Wlasiuk and 
Vercelli 2012).                
There are environmental exposures, genetic, epigenetic and microbe-associated 
factors that influence the infant’s gut colonisation (Fouhy et al. 2012, Lozupone et al. 
2012). Numerous factors are involved in inducing tolerance to large quantities and 
varieties of food and bacterial antigens. The composition of intestinal microbiota, 
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gut permeability and exposure to food antigens affect the development of the gut 
immune system and tolerance during the first months of life. Factors that mostly 
influence gut microbiota profiles in infancy are the mode of the delivery (Azad et al. 
2013, Isolauri 2012, Jakobsson et al. 2014, Penders et al. 2014), the quality of 
breastmilk (Azad et al. 2013, Isolauri 2012) and the number of older siblings 
(Penders et al. 2014) .        
An aberrant composition of the gut microbiota has been shown to associate with 
the onset of inflammatory bowel disease and necrotising enterocolitis (Carlisle and 
Morowitz 2013, Leone et al. 2013). Also, early studies showed that infants in 
Estonia and infants in Sweden were different with respect to microflora, with a low 
prevalence of allergies in the former and a high prevalence of allergies in the latter 
(Bjorksten et al. 1999, Sepp et al. 1997) and after this pioneer observation the 
association between gut microflora and allergic diseases has keenly been 
investigated. It has been stated that disturbances in gut colonisation patterns and 
reduced microbial diversity are associated with the development of allergic diseases 
(West 2014). However, it is still unknown what the content of a healthy human gut 
microbiota which protects from allergic diseases later on is like. 
There are several microbial species in the gut which have been found to associate 
with atopic diseases (Penders et al. 2007). It has been newly discovered by using 
pyrosequencing that lower abundance of the genus Bacteroides and lower diversity 
of Bacteroidetes in gut microbiota have been associated with birth by Caesarean 
(Azad et al. 2013, Jakobsson et al. 2014) and thus may explain the findings that 
children who have been born by Caesarean delivery have an increased risk of 
asthma and atopy (Neu and Rushing 2011). In addition gut colonisation by 
Clostridia in early infancy increased the risk for atopic dermatitis (Penders et al. 
2014). Furthermore, it has been discovered that Bifidobacterium longum was more 
abundant in the faecal samples of the nonwheezing children who were exposed to 
pets in infancy than in the samples of those children who were wheezing and 
nonexposed to pets (Nermes et al. 2013). There was also more Bifidobacterium 
breve in the samples of the nonexposed children (Nermes et al. 2013). 
Calprotectin is a 36 kDa cytosolic protein complex composed of 8 kDa and 14 
kDa subunits (Fagerhol et al. 1980). It is produced by neutrophilic granulocytes and 
monocytes, and can bind zinc and calcium ions (Fagerhol et al. 1980). Calprotectin 
is released via neutrophil activation or monocyte-endothelial cell adhesion after 
stimulation of various factors such as IL-1β, IL-6 and TNF-α cytokines (Mahnke et 
al. 1995, Striz and Trebichavsky 2004) under conditions of cellular stress, and it can 
be detected in faeces, urine, plasma, and other body fluids as an inflammatory 
marker (Foell et al. 2007). Faecal calprotectin levels have been shown to be 
relatively high during the first year of life (Kapel et al. 2010). 
Increased levels of calprotectin indicate for instance bacterial infections, 
rheumatoid arthritis, inflammatory bowel diseases, celiac disease and other 
inflammatory conditions where the permeability of the gut is increased (Sidler et al. 
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2008). Interestingly, it has been newly suggested that calprotectin could be a useful 
marker in predicting the course of atherosclerotic process, coronary artery disease 
and the outcomes of acute coronary syndrome (Kruzliak et al. 2014). Only few 
studies have investigated the association between faecal calprotectin and allergic 
diseases. In a French study allergic infants had higer faecal calprotectin values than 
healthy ones but the difference was not statistically significant (Waligora-Dupriet et 
al. 2011). Another study did not find any association between faecal calprotectin 
values during infancy and developmet of allergic diseases by the age of two years 
(Baldassarre et al. 2011). More reseach of the association between faecal 
calprotectin and allergic diseaseas is needed. 
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3 AIMS OF THE STUDY 
The aim of the current thesis was to investigate the role of inflammation and the 
environmental exposures causing inflammation in the development of allergic 
diseases in children. The specific aims were: 
 
1.   To examine the cross-sectional association between different environmental 
factors and low-grade inflammation measured with serum high-sensitivity C-
reactive protein (Study I) 
 
2.  To examine the association between low-grade inflammation measured with 
serum high-sensitivity C-reactive protein at the age of one and the development 
of atopy, asthma and atopic dermatitis by the age of 4.5 years (Study II) 
 
3.  To investigate the cross-sectional association between moisture damage and 
systemic inflammation in children at the age of six years (Study III) 
 
4.  To investigate the relation between gut inflammation at the age of two months 
and atopy, asthma and atopic dermatitis by the age of six years (Study IV) 
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3.1 The study question 
The main study questions of the present thesis can be summarized as in Figure 1. 
 
 
 
 
              ?               ? 
 
 
 
 
 
 
 
 
Figure 1.  The illustration of the study questions. 
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4 MATERIALS AND METHODS 
4.1 Study population—PASTURE (I, II and IV) 
The study population consisted of the Protection against Allergy Study in Rural 
Environments (PASTURE) birth cohort (von Mutius et al. 2006) which is an 
ongoing birth cohort study in Austria, Finland, France, Germany and Switzerland. 
Between years 2002–2005, pregnant women who lived on farms and pregnant 
women who lived in other rural areas than farms were invited to the study. 
Altogether 1133 children were included in the study between August 2002 and 
March 2005 (Figure 2). The inclusion criteria for the mothers were as follows: living 
on a farm with livestock or in rural areas, a maternal age of ≥ 18 years, a singleton 
pregnancy, delivery in one of the study hospitals, no plans of moving from the study 
area, the native language Finnish and siblings of the study child not participating in 
the study. The mothers were excluded from the study after the delivery if there was a 
parturition at less than 37 weeks of gestation, home delivery, infants’ congenital 
abnormalities or a failure to obtain cord blood samples. The families who did not 
have a phone were not recruited. 
The study protocol was approved by the Research Ethics Committees in every 
study centre and written consents were obtained from the parents of the participating 
children. 
CRP values (I, II) and specific IgE-values (I, II, IV) were obtained from venous 
blood samples at three time points: when the children were one, 4.5 and six years 
old. Faecal samples were collected at the age of two months (IV). 
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Figure 2.  Recruitment of the PASTURE study population. 
  (Modified from Ege et al. 2008) 
4.2 Study population—LUKAS (III) 
The LUKAS (”Lapsuuden kasvuympäristö ja allergiat”)	   study consists of two 
Finnish birth cohort studies (Karvonen et al. 2009): the Finnish part of the 
PASTURE cohort (LUKAS1) and an extended cohort LUKAS2 (Figure 3). 214 
children were enrolled in the LUKAS1 study between September 2002 and May 
2004. All pregnant women who lived on farms with livestock and an equally-sized 
group of non-farming women who lived in rural areas were invited to the study 
during the third trimester of pregnancy in the areas of Kuopio, Jyväskylä, Joensuu 
and Iisalmi hospitals in Eastern and Middle Finland. 
228 children were recruited in the LUKAS2 study. The inclusion and exclusion 
criteria of the LUKAS2 were otherwise similar to those in the PASTURE study; only 
the parental occupation and the living area were excluded from the criteria this time. 
All the mothers who were to give birth in the Kuopio University Hospital between 
May 2004 and May 2005 and who lived in non-apartment households were invited to 
participate in the study. For laboratory logistic reasons, the women delivering between 
Thursday afternoon and Sunday morning were excluded from the extended cohort.  
The ethical permission of the LUKAS study was granted by the Research Ethics 
Committee of the Hospital District of Northern Savo, Kuopio, Finland. Written 
consents were acquired from the parents of the participating children. 
Venous blood samples for leucocyte, cytokine and CRP analyses and fractional 
exhaled nitric oxide samples were collected at the age of six years (III). 
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Figure 3.  Recruitment of the LUKAS study population. 
(Modified from Karvonen et al. 2009) 
4.3 Questionnaires 
The questionnaires were self-administered by parents during the third trimester of 
pregnancy, and when the children were 2, 12, 18, 24, 36, 48, 60 and 72 months old. 
Study nurses administered the two-month questionnaire in the PASTURE study (and 
in the LUKAS1 study) by interviewing parents during a home visit. The 
questionnaires enquired information on the end of the pregnancy, the mode of 
delivery, the child’s weight and height, the use of medication by the mother or the 
child, breastfeeding, dog and cat ownership, mother working in or child staying in a 
cow shed or hay barn passive smoking, the symptoms and diseases of the children, 
the consumption of food and farm milk and day care attendance. 
4.3.1 Health outcomes 
Asthma was defined as parent-reported doctor-diagnosed asthma and/or asthmatic 
(obstructive) bronchitis more than once during his/her first four years of life (II). 
Asthmatic (obstructive) bronchitis more than once is related to the condition often 
termed recurrent wheezing, but is more severe, as it requires contact with a doctor. 
Children who already had asthma or had had asthmatic bronchitis more than once 
before the measurement of the CRP values (at the age of one year) were excluded 
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from the analyses (II). In study IV asthma was defined as parent-reported doctor-
diagnosed asthma and/or asthmatic (or obstructive) bronchitis more than once during 
the six-year follow-up.  
 ‘Atopic dermatitis’ was defined as parent-reported doctor-diagnosed atopic 
dermatitis at least once during the child’s first four years (II) or during the first six 
years (IV) of life. Children who already had had atopic dermatitis before the 
measurement of the CRP values (at the age of one year) were excluded from the 
analyses (II). 
Any wheezing, wheezing apart from cold, cough apart from cold, nocturnal 
cough, rhinitis apart from cold or rhinoconjunctivitis apart from cold was defined as 
a parent-reported symptom, which occurred less than once a month or more 
frequently between five and six years of age (III). Children who already had asthma 
diagnosis were excluded from the analyses of these symptoms (III). 
Otitis media, laryngitis and diarrhea (for at least two days) were defined as a 
positive answer for the question about having a given infection between the ages of 
five and six years (III). A common cold with a fever (>38.5°C) was defined as at 
least two episodes of common cold with a fever between the ages of five and six 
years (III).  
4.3.2 Confounders 
All models were adjusted for study centre (I, II and IV) or study cohort (III), living 
on a farm and gender. Other confounding factors were the maternal history of 
allergic diseases (asthma, atopic dermatitis or allergic rhinitis, II, III and IV), the 
number of older siblings (II, III and IV), day care with other children than siblings 
(I), smoking during pregnancy (III and IV), breastfeeding (IV), BMI (I and III), the 
season of the CRP sampling at the age of 4.5 years (I) and the recent nitrate 
consumption of the child (III). 
The selection of adjusting confounders was performed by two different methods: 
the adjusting confounders were at least marginally significantly (p < 0.10) associated 
with CRP values in the univariate analysis (I, II and IV) or a confounder changed the 
estimates more than 10 % (tested with the relationship between exposures to 
moisture damage or mould and CRP values, III). Other factors tested were the 
paternal history of allergic diseases, parental educations, the age of mother, birth 
weight, the mode of delivery, second-hand smoke, dog and cat ownership, mother 
working in a cow shed and hay barn during pregnancy, the presence of a dung hill 
near the residence and the consumption of farm milk. For analyses on FeNO values 
the season of the measurement, recent eating, eating of nitrates, exercise and passive 
smoking exposure before the FeNO measurements were tested and recent nitrate 
consumption was included in the final model (III). There was neither clinical 
examination by a doctor nor viral sample collection from the children at the time of 
the blood extractions. 
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4.4 CRP values 
The CRP values at the age of one year (II) were measured using ELISA method 
(BenderMedSystems human CRP, Vienna, Austria). The sensitivity of the assay was 
3.0*10-6 mg/l. The CRP values at the ages 4.5 (I) and six (III) years were measured 
by SYNCHRON® System(s) (Beckman Coulter Inc., Fullerton, CA, USA) in 
Marburg, Germany, according to the manufacturer’s instructions. The method is 
based on the highly sensitive Near Infrared Particle Immunoassay rate. The 
detection limit was 0.20 mg/l. Children who had CRP values at any time point more 
than 5 mg/l were excluded from the analyses to exclude the effect of acute infection 
on inflammatory markers. 
4.5 Specific IgE values 
Specific immunoglobulin E (sIgE) to 19 common allergens were analysed using the 
Allergy Screen Test Panel for Atopy (Mediwiss Analytic, Moers, Germany) 
(Herzum et al. 2005). The 13 inhaled allergens determined were two house dust 
mites (Dermatophagoides pteronyssinus and D.farinae), seven types of pollen 
(alder, birch, European hazel, grass pollen mixture, rye, mugwort and plantain), cat, 
horse and dog dander, and the mould Alternaria alternata. The six food allergens 
tested were hen’s egg, cow’s milk, peanut, hazelnut, carrot and wheat. The IgE 
analyses were done in Marburg, Germany. 
Atopy was defined as any sIgE concentration at least 0.35 kU/L at the age of one 
year (II) and at least 0.70 kU/L at the age of 4.5 (I, II) and six years (IV). Atopic 
sensitisation to inhalant allergens was defined as at least one sIgE concentration to 
any of the 13 inhalant allergens at least 0.35 kU/L, and sensitisation to food 
allergens as at least one sIgE concentration to any of the six food allergens at least 
0.35 kU/L at the age of one year and at least 0.70 kU/L at the age of 4.5 and six 
years. The following eight inhalation allergens were considered as seasonal: alder, 
birch, hazel or rye pollen, grass pollen mix, mugwort, plantain, and Alternaria 
species. Dermatophagoides pteronyssinus and farinae, cat, horse, and dog dander 
were considered as perennial allergens (Ege et al. 2008). 
4.6    Cytokines 
Processing of the blood started within 27 hours after blood drawing. Diluted blood 
samples (1:8) were incubated for 24 hours with the following stimuli: a combination 
of phorbol 12-myristate 13-acetate (5 ng/mL) and ionomycin (1 µg/mL, 
PI),   lipopolysaccharide (LPS 0.1 µg/mL) or peptidoglycan (PPG 10 µg/ml) alone 
and analysed for the following proinflammatory cytokines: Interleukins 1β and 6 
(IL-1β, IL-6) and tumor necrosis factor (TNF-α). All stimulants were from Sigma, 
Deisenhofen, Germany. The concentrations of all cytokines were measured by using 
multiplexed cytometric bead array (CBA) according to the manufacturer's 
instructions (BD) in Marburg, Germany. All the cytokines were standardized by the 
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white blood cell counts. The detection limits were 2.3 pg/ml for IL-1β, 0.7 pg/ml for 
TNF-α and 1.6 pg/ml for IL-6 cytokines. Due to product mislabeling by the 
manufacturer (PAA Laboratories) the whole blood cultures of 50 study children 
contained fetal bovine serum supplement (FBS) with significant impurities and thus 
had to be excluded from the statistical analyses. 
4.7 Fractional exhaled nitric oxide (FeNO)  
The fraction of nitric oxide in the expiratory air was analysed by Offline Sampling 
using OfflineKits (EcoMedics AG, Dürnten, Switzerland) and Mylar Bags® 
(Quintron, Cedar Rapids, Iowa). Children breathed into the Mylar Bags® three 
times using the mobile offline device and the exhaled nitric oxide was measured by 
the NO-analyser CLD 88sp (EcoMedics AG) within 12 hours after sampling.  The 
mean of the FeNO values (ppb) was used in the analyses. 12 participants with 
reported intake of inhaled steroids in the week before the FeNO sampling were 
excluded from the analyses. 
4.8 Moisture damage and mould in home 
In the LUKAS study, a trained civil engineer of the study group inspected the homes 
for moisture damage and visible mould when the child was approximately six years 
old. The engineer had years of experience in the use of a standard protocol 
(Nevalainen et al. 1998).  
   The homes were inspected for signs of moisture on the surfaces and the structures 
using a pre-designed checklist without opening the structures (Pekkanen et al. 2007, 
Nevalainen et al. 1998). Moisture damage and mould in the homes were categorised 
according to their locations: kitchen, living room, bathroom, child’s bedroom and 
other living area. Due to small number of moisture damage and mould in homes, 
moisture damage in the child’s main living areas were combined and analysed 
together: living room, kitchen and child’s bedroom. 
Moisture damage was classified into three classes, i.e. no damage, minor damage 
and major damage, based on a six-point “need for repair” estimation scale 
(Nevalainen et al. 1998) and the area of the damage (Pekkanen et al. 2007). Classes 
0 and 1 meant damage with no need for repair or only cosmetic repair; class 2 meant 
a repair of surface materials needed; class 3 meant a repair of structural components 
needed; and classes 4 and 5 meant more extensive repair needed. “No damage” was 
defined as need-for-repair classes 0 or 1. “Major damage” was defined as either a 
need-for repair class 2 with the area of damage ≥1 m2 or a need-for-repair class 3 
with the area of damage ≥0.1 m2, or a need-for-repair class 4 or 5 (Karvonen et al. 
2009, Pekkanen et al. 2007). Other damage was classified as “minor damage”. 
During the home inspection, the observed mould was also categorised into three 
classes: no mould, spots of mould and visible mould. Moisture damage, mould spots 
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or visible mould on silicone sealants in the kitchen were excluded from the 
definition of moisture damage or mould. 
4.9 Calprotectin 
Faecal samples were stored at -75 °C. A beaker in the bottom cap of the Calpro 
Extraction Device (Calpro AS, Lysaker, Norway) was filled with thawed and 
homogenized stool sample, avoiding seeds and grains (∼100 mg). The extraction 
tube was filled with 4.9 mL extraction buffer and vortexed for 30 s. The mixing was 
continued in a shaker at 1000 rpm for 3 min or until only solid particles remained. 
The samples were centrifuged for 10 minutes at 10 000 g at room temperature. 
Supernatant was collected and stored at -20°C. 
Calprotectin levels were determined using Calprolab calprotectin ELISA tests 
(Calpro AS, Lysaker, Norway). 20 µL of extract was mixed with 980 µL of sample 
dilution buffer. Standard and positive controls were performed in duplicate. The 
optical density was read at 405 nm using an ELISA reader. Samples below the 
lowest measurable concentration (39.2 µg/g) were given an arbitrary value of 19.6 
µg/g. 
4.10 Selection of the subgroup of 120 children for faecal 
microbial determination  
In the subgroup of the cohort the composition of faecal microbiota was analysed 
using 16S RNA pyrosequencing. The children were included for the selection of the 
subgroup if they were breast-fed at the age two months, the concentration of 
calprotectin was above the detection limit, data was available for atopic dermatitis 
and asthma at the age of six years, and the amount of faecal sample was sufficient 
for DNA extraction.  
A total of 40 case samples were selected (starting from the first applicable 
sample with calprotectin in the 90th percentile), calprotectin values ranging from 
517.6 to 1542.0 µg/g. The control samples were randomly selected from the 
applicable samples with calprotectin value below the 90th percentile, two per case 
sample from the same center (N=80). 
4.11 Pyrosequencing 
From each sample, the 16S rRNA genes were amplified using a primer set 
corresponding to primers 27F-degS (van den Bogert et al. 2011) and 534-R (Wu et 
al. 2010). These PCR primers target the V1, V2, and V3 hypervariable regions of the 
16 S rRNA; 27-degS was chosen in particular because it appears to provide a more 
complete assessment of actinobacterial abundance (van den Bogert et al. 2011). 
Pyrosequencing was performed using a Roche FLX Genome Sequencer at 
DNAvision (Liège, Belgium) using their standard protocol (De Filippo et al. 2010).  
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4.12 Statistical analyses 
The CRP values at any time points, calprotectin values or cytokine concentrations 
were not normally distributed, and were therefore categorised into two or four 
groups using the 25th, 50th and 75th percentile cut points (I—IV). In addition the 
90th percentile cut point was used in study IV. Also, leucocyte and FeNO values 
were divided into two groups using the 75th percentile cut point (III). 
Different cytokines stimulated with same stimulant correlated positively and 
therefore the combination variables of IL-1β, IL-6 and TNF-α were calculated by 
taking an average of the ranks of the three cytokines within each stimulation. Also 
these combination variables were categorised into two classes based on the 75th 
percentile cut point. 
The results were given as median values with interquartile ranges. P-values for 
the comparisons between different categories in univariate analyses were calculated 
by the Mann–Whitney U-test and the Kruskal–Wallis tests (I, II, IV). Bivariate 
analyses were conducted by Pearson χ2 – test or Fisher’s exact test in categorised 
variables (I—IV). Correlations between nonparametric variables were calculated as 
Spearman’s correlation coefficients. 
Logistic regression was used to analyse the associations between CRP values, 
calprotectin values and health outcomes and atopy (I, II, IV). Logistic regression 
was also used to analyse the associations between moisture damage/mould problems 
and cytokine, CRP, leucocyte and FeNO values and health outcomes (III) and to 
analyse the associations between CRP values and environmental determinants (I, II). 
Furthermore, the associations between CRP levels and environmental factors were 
evaluated among atopic and non-atopic children separately (I, II).  The results were 
presented as adjusted odds ratios (aORs) with their 95 % confidence intervals (95 % 
CI). P-values lower than 0.05 were considered statistically significant. Statistical 
analyses were performed with either PASW Statistics 18.0 (SPSS Inc., Chicago, IL, 
USA, I, II and IV) or with SAS 9.3 for Windows (III). 
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5 RESULTS 
5.1 Low-grade inflammation, environmental factors and health 
outcomes (I, II) 
At the age of one year there were 636 study children who had CRP values available 
and all of them had CRP value lower than 5 mg/l and the median value was 0.06 
mg/l with interquartile range 0.04–0.19 mg/l. At the age of 4.5 years CRP values 
were available for 694 children and some children (n = 41, 5.9 %) had CRP values 
over 5 mg/l and were therefore excluded from the statistical analyses. Median value 
was 0.22 mg/l with interquartile range 0.00–0.75 mg/l. 
5.1.1 Environmental factors 
The girls had higher CRP levels at the age of one and 4.5 years than boys (p-
value=0.045 and p-value<0.001 respectively) and the levels were higher in children 
who were obese or very obese at the age of 4.5 years compared to healthy weight 
children (aOR 4.47, 95 % CI 1.94–10.31). Values measured in summer at the age of 
4.5 years were lower than in other seasons (aOR 0.44, 95 % CI 0.24–0.80). The 
French children had higher CRP values compared with the other children in a 
univariate test at the age of 4.5 years (medians: 0.35 vs. 0.00 mg/l; p = 0.003) and 
the values also tended to be higher if a child was in a day-care with 11 or more 
children at the age of 4.5 years (medians: 0.29 vs 0.00 mg/l; p = 0.069). The CRP 
values did not differ significantly between farmers’ and non-farmers’ children at the 
age of 4.5 years and there were no association between the CRP levels and the 
number of siblings (data not shown). 
The CRP levels at the age of 4.5 years tended to be higher in children who had 
been breastfed for less than 2 months, but the adjusted association was not 
significant (Table S1, I). Furthermore, no significant associations were detected 
between environmental and farming factors and the levels of CRP at the age of 4.5 
years after adjustments (data not shown). In addition, no significant associations 
were detected between the children who did or did not drink farm milk (data not 
shown). 
After dividing children into two groups by atopy at the age of 4.5 years, non-
atopic children who were visiting stables weekly had significantly lower CRP levels 
at the age of 4.5 years compared to those who did not spend time in stables at all 
(Table 1). This was not seen in atopic children (Table 1). Further, atopic children 
whose mothers had been smoking recent years had significantly higher CRP levels 
and in addition, they also tended to have higher levels of CRP if the mother had 
smoked during pregnancy compared to the children of the non-smoking mothers 
(Table 1). There were no associations between CRP values at the age of 4.5 years 
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and parental farming, farm milk consumption, duration of breastfeeding, contact 
with cats or dogs at home or duration of time spent in hay barns. 
In univariate analyses, CRP values at the age of one year were higher among 
children who had siblings (p-value=0.017) and were in contact with other children at 
day-care (p-value=0.004). In multivariate analyses, lower CRP values at the age of 
one year were detected among atopic children if there had been farm milk 
consumption of a child, dogs or both dogs and cats at home (Table 3, II) or a mother 
visiting stables weekly during pregnancy or recently compared with the children 
who did not have these exposures (Table 2). These associations were not seen 
among non-atopic children at the age of one year (Table 2). 
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n CRP* aOR# (95th CI) n CRP* aOR# (95th CI) 
Duration of breastfeeding (months)
No breastfeeding 35 0.28 (0.00-0.88) 1 20 0.11 (0.00-0.45) 1
0.5-2 39 0.36 (0.00-1.24) 1.36 (0.49-3.81) 28 0.34 (0.00-0.99) 9.44 (1.01-88.55)
2-6 95 0.23 (0.00-0.77) 0.84 (0.33-2.12) 73 0.00 (0.00-0.53) 4.40 (0.51-38.39)
≥6 188 0.24 (0.00-0.75) 0.77 (0.32-1.88) 174 0.00 (0.00-0.73) 8.40 (0.98-72.33)
p-value 0.218 0.593 0.282 0.106
Child's staying in stable weekly in last 12 months
No (<15min) 164 0.27 (0.00-0.93) 1 118 0.00 (0.00-0.51) 1
15 min−10h 157 0.24 (0.00-0.78) 0.40 (0.16-0.96) 149 0.00 (0.00-0.77) 1.23 (0.48-3.11)
≥ 10 hours 36 0.00 (0.00-0.63) 0.25 (0.07-0.90) 28 0.22 (0.00-0.70) 0.80 (0.19-3.36)
p-value 0.411 0.072 0.849 0.674
Child's farm milk consumption (dL-day) in last 12 months
0 200 0.27 (0.00-0.77) 1 154 0.00 (0.00-0.51) 1
0-2 65 0.00 (0.00-0.78) 1.21 (0.55-2.64) 47 0.00 (0.00-0.95) 1.88 (0.77-4.61)
> 2 92 0.27 (0.00-0.98) 1.48 (0.74-2.96) 94 0.00 (0.00-0.63) 1.24 (0.55-2.79)
p-value 0.584 0.535 0.916 0.370
Maternal smoking during pregnancy
Never smoked 227 0.24 (0.00-0.76) 1 182 0.10 (0.00-0.68) 1
Not during pregnancy 90 0.34 (0.00-0.97) 1.41 (0.79-2.52) 72 0.00 (0.00-0.40) 0.52 (0.22-1.20)
During pregnancy 40 0.25 (0.00-0.83) 1.24 (0.55-2.79) 41 0.26 (0.00-1.53) 1.91 (0.83-4.41)
p-value 357 0.272 0.491 295 0.179 0.034
Maternal smoking (during last 2 years)
No 319 0.26 (0.00-0.83) 1 255 0.00 (0.00-0.58) 1
Yes 38 0.10 (0.00-0.75) 0.94 (0.41-2.17) 40 0.00 (0.00-1.20) 2.51 (1.12-5.59)
p-value 0.637 0.882 0.694 0.025
Table 1. Associations between CRP and different environmental and farming factors by 
in relation to any atopic sensitisation at the age of 4.5 years.
N o n-­‐ s e ns it is e d 	  S e ns it is e d
* CRP values are presented as median values w ith interquartile range and p -values are estimated by Mann-
Whitney or Kruskal-Wallis test.
# CRP values are presented in tw o groups according to 75th cut-off points (≥0.75mg/l and < 0.75mg/l) and 
comparison betw een tw o groups are show n values as odds ratios (OR) w ith their 95% confidence intervals (CI). P-
values are obtained from the trend test (Wald) in logistic regression models. Odds ratios are adjusted for parental 
farming, country, season of measurement, gender, BMI and day care w ith other children than siblings. P-values are 
obtained from the trend test (Wald).  
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n CRP* aOR# n CRP* aOR#
Duration of breastfeeding (months)
No breastfeeding 23 0.08 (0.04/0.26) 1 19 0.08 (0.04/0.64) 1
0.5-2 40 0.05 (0.03/0.15) 0.82 (0.25-2.74) 11 0.06 (0.03/0.14) 0.56 (0.08-4.06)
2-6 114 0.06 (0.05/0.17) 0.90(0.32-2.58) 45 0.06 (0.04/0.12) 0.66 (0.16-2.70)
6 or more 276 0.06 (0.04/0.15) 1.02 (0.38-2.77) 98 0.07 (0.05/0.28) 1.19 (0.31-4.51)
p-value 0.212 0.942 0.247 0.594
Child's staying in stable weekly in last 10 months
No 246 0.06 (0.04/0.13) 1 91 0.07 (0.05/0.29) 1
Yes 213 0.07 (0.04/0.19) 0.87 (0.46-1.66) 84 0.06 (0.04/0.19) 0.36 (0.12-1.05)
p-value 0.586 0.673 0.355 0.060
Child's farm milk consumption
No 311 0.06 (0.04/0.14) 1 114 0.07 (0.04/0.30) 1
Only boiled 67 0.06 (0.04/0.26) 1.14 (0.58-2.22) 29 0.06 (0.04/0.08) 0.16 (0.04-0.60)
Both unboiled and boiled 34 0.06 (0.03/0.37) 1.16 (0.48-2.81) 18 0.06 (0.04/0.14) 0.18 (0.04-0.85)
Only unboiled 41 0.07 (0.05/0.20) 1.29 (0.57-2.91) 12 0.05 (0.03/0.18) 0.41 (0.09-1.97)
p-value 0.928 0.581 0.283 0.026
Maternal smoking (during last 10 months)
No 395 0.06 (0.04/0.15) 1 151 0.06 (0.04/0.20) 1
Yes 58 0.06 (0.04/0.20) 1.31 (0.68-2.55) 22 0.08 (0.05/0.37) 2.21 (0.76-6.47)
p-value 0.715 0.420 0.387 0.147
Mother's staying in stable weekly during pregnancy
No 180 0.06 (0.04/0.13) 1 60 0.07 (0.05/0.40) 1
Yes 279 0.07 (0.04/0.20) 1.27 (0.69-2.33) 115 0.06 (0.04/0.29) 0.24 (0.07-0.79)
p-value 0.183 0.444 0.129 0.019
Mother's staying in stable weekly in last 10 months
No 257 0.06 (0.04/0.14) 1 86 0.07 (0.04/0.28) 1
Yes 202 0.07 (0.04/0.19) 0.88 (0.32-2.46) 89 0.06 (0.04/0.20) 0.13 (0.02-0.96)
p-value 0.322 0.808 0.675 0.045
Table 2. Associations between  different environmental and farming factors and CRP at 
the age of 1 year in children who have no signs of IgE sensitisation  and in children 
who have developed allergen specific IgE response at the age of one year.  
Non-sensitised Sensitised
*CRP values are presented as median values w ith interquartile range. P-value estimated by Mann-Whitney or 
Kruskal-Wallis test.
# CRP values are presented in tw o groups according to 75th cut-off points (≥0.19mg/l and < 0.19mg/l) and 
comparison betw een tw o groups are show n values as odds ratios (OR) w ith their 95% confidence intervals (CI).  
P-values are obtained from the trend test (Wald) in logistic regression models. Odds ratios are adjusted for 
country, gender, farmer, siblings and day care w ith other children than siblings.
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5.1.2 Atopy, asthma and atopic dermatitis  
At the age of 4.5 years the prevalence of atopy was 45.2 % (295/652), and the 
prevalence of atopic sensitisation against any inhalant or against any food allergens 
was 32.7 % (213/652) and 27.3 % (178/652), respectively. The prevalence of atopic 
sensitisation against perennial or seasonal allergens was 21.9 % (143/652) and 18.7 
% (122/652), respectively. If a child had a CRP level lower than the 75th percentile 
there was a lower risk of sensitisation to inhaled and seasonal allergens (aOR 0.57, 
95 % CI 0.37–0.88 and aOR 0.58, 95 % CI 0.35–0.98 respectively) compared to the 
non-detected levels of CRP but the associations was not seen if the CRP levels were 
over the 75th percentile or when the CRP was used as a continuous variable (data not 
shown).  
At the age of one year, 27.6 % (N = 175) of the study children were atopic. 
Between ages one and 4.5 years 60 (12.4 %) of the study children developed atopic 
dermatitis, 68 (13.1 %) developed asthma/asthmatic bronchitis and at the age of 4.5 
years 215 (48.0 %) were atopic. 
Among non-atopic children at the age of one year, the children whose CRP levels 
were over the 75th percentile, had a significantly lower risk of atopy at the age of 4.5 
years (aOR 0.48, 95 % CI 0.24–0.95) compared with those children whose CRP 
values were in the lowest quartile. There was a significant inverse dose-dependent 
trend: the higher the CRP value at the age of one year, the lower the risk for atopy 
later on (p-value=0.014). There were no significant associations between the CRP 
levels at the age of one year and the risk of atopic dermatitis or asthma/asthmatic 
bronchitis between ages one and four years (Table 1, II). 
Furthermore, there was a significant inverse dose dependent trend between CRP 
values and sensitisation to inhalant allergens (p-value=0.017). In addition, among 
atopic children at the age of one year, the risk of atopic dermatitis later on tended to 
be associated with low CRP values: the risk was significantly lower if the CRP value 
was between the 50–75th percentile compared with values in the lowest quartile 
(aOR 0.11, 95 % CI 0.02–0.77). 
There were no significant associations between CRP values at the age of one 
year and the development of atopic dermatitis or asthma/asthmatic bronchitis 
between ages one and four years in the total study population (Table 2, II). A 
tendency of an inverse dose dependent trend was seen: the higher the CRP value at 
the age of one year, the lower the risk of atopy at the age of 4.5 years (p-
value=0.077). 
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5.2 Moisture damage and mould in the home and inflammatory 
markers (III) 
5.2.1 CRP, leucocytes, FeNO  
At the age of six years there were 291 children who had CRP values available in the 
LUKAS study, but 10 (3.4 %) of them had a value over 5 mg/l and they were 
excluded from the analyses. The median value was 0.25 mg/l and interquartile range 
0.00–0.66 mg/l. Leucocyte values were available from 284 children: the median 
value being 7.00*103/nL with the interquartile range 5.90–8.10 *103/nL. FeNO 
values were available from 292 children and the median value was 5.99 ppb with an 
interquartile range 4.54–7.81 ppb. 
Major moisture damage in child’s main living areas (living room, kitchen or 
child’s bedroom) was associated with high levels (>75th percentile) of CRP (Table 
3). There were no significant associations between moisture damage/mould 
problems and leucocyte or FeNO values (data not shown). 
5.2.2 Cytokines  
Major moisture damage in child’s main living areas (living room, kitchen or child’s 
bedroom) tended to associate with high levels (>75th percentile) of most of the 
analysed proinflammatory cytokines. These associations reached statistical 
significance for IL-1β in PI-stimulated whole blood (Table 3) and for the combined 
variable of IL-1β, TNF-α and IL-6 cytokines in LPS-stimulated whole blood (aOR 
3.10, 95 % CI 1.01–9.55). 
In addition, moisture damage with mould in the bathroom was associated with 
high levels of IL-1β (in PI-stimulated whole blood), TNF-α (in LPS-stimulated 
whole blood) and IL-6 (PI-stimulated whole blood) cytokines (Table 3). 
Furthermore, moisture damage with mould in the bathroom was associated with high 
levels of combined variable of IL-1β, TNF-α and IL-6 cytokines in PI-stimulated 
whole blood (aOR 6.02, 95 % CI 1.06–34.12). There were no statistically significant 
associations between the presence of mould in child’s main living areas or in other 
living areas and any of the inflammatory markers (data not shown). 
Although several positive associations were observed between moisture damage 
and mould and symptoms, the associations were mostly non-significant and in many 
places conflicting. Moisture damage with mould in the bathroom increased the risk 
of rhinitis apart from cold (aOR 5.45, 95 % CI 1.03–28.73) and rhinoconjunctivitis 
apart from cold (aOR 21.17, 95 % CI 2.57–174.58) when asthmatic children were 
excluded from the analyses. On the contrary, moisture damage in child’s main living 
areas and moisture damage with mould in the bathroom had an inverse association 
with rhinitis apart from cold (aOR 0.20, 95 % CI 0.04–0.93 and aOR 0.20, 95 % CI  
0.05–0.75 respectively) when asthmatic children were excluded. There were no 
significant associations between moisture damage/mould problems in home and 
common cold with fever, otitis, laryngitis or diarrhea (Table S4, III). 
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5.3 Intestinal inflammation, environmental factors and health 
outcomes (IV) 
At the age of two moths there were 758 faecal calprotectin samples available and the 
median value was 163.50 µg/g with the interquartile range 88.59–283.24 µg/g. Due 
to the association of calprotectin with breast-feeding, the levels of calprotectin in 
breast milk samples from 115 Finnish mothers were analysed, the levels of 
calprotectin in breast milk and faeces did not correlate significantly with each other 
(R= 0.104 and p-value 0.271). 
5.3.1 Environmental factors 
In univariate analyses, faecal calprotectin levels varied between the study centres, 
German children having significantly higher levels of calprotectin at the age of two 
months compared to the other centres (p-value=0.001). The farmers’ children had 
increased levels of faecal calprotectin when compared to the non-farmers’ children 
(p-values=0.003). Also, increased levels of faecal calprotectin were seen among 
children with one or more siblings when compared to the children without siblings 
(p-value<0.001) and among exclusively and partially breast-fed children when 
compared to non-breast fed children (p-value<0.001). The infants of the mothers 
who did not smoke had higher levels of faecal calprotectin when compared to the 
infants of the mothers who smoked during pregnancy or who had been smoking 
before pregnancy (p-value=0.003).  
5.3.2 Atopy, asthma and atopic dermatitis  
When the levels of faecal calprotectin were divided into four groups using quartiles, 
there was no significant dose-dependent association with the risk of allergic diseases 
or atopy at the age of six years, although, there tended to be a trend for the 
association with asthma (p-value=0.093).  
The 90th percentile of calprotectin levels in the whole cohort was used as a cut-
off for the significantly increased calprotectin levels indicating a high level of 
intestinal inflammation, and the children who had very high calprotectin levels (in 
the 90th percentile) had an increased risk of developing atopic dermatitis and 
asthma/asthmatic bronchitis by the age of six years when compared to the children 
who had calprotectin levels below the 90th percentile (Table 4).  
There were no significant associations between calprotectin values and atopy at 
the age of six years (Table 4). 
5.3.3 Bacterial associations 
For gut microbiota analyses, the composition of the gut microbiota in a selected 
subgroup with faecal calprotectin below and above the 90th percentile were 
performed. The infants who had faecal calprotectin levels above the 90th percentile 
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had significantly lower amount of Escherichia in their faecal microbiota when 
compared to the infants who had faecal calprotectin levels below the 90th percentile 
(p-value=0.019).  
Children with faecal calprotectin levels lower than 200µg/g had significantly 
lower amount of Lactobacilleae in faeces than children with faecal calprotectin 
levels in between 200 µg/g and 90th percentile (p-value=0.016) or than children with 
calprotectin levels above the 90th percentile (p-value=0.011). However, the amount 
of Lactobacilleae did not significantly associate with the very high levels of faecal 
calprotectin (the 90th percentile) when compared to the faecal calprotectin values 
below the 90th percentile (p-value=0.125).  
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6 DISCUSSION 
6.1 Environmental factors inducing inflammation 
6.1.1 Early environment and low-grade inflammation 
Earlier studies have suggested that there may be factors in an early environment that 
could induce low-grade inflammation in children and the present study investigated 
the environmental and farming factors that could possibly induce low-grade 
inflammation and thereby give protection from allergies (Marschan et al. 2008, 
Viljanen et al. 2005). To my knowledge, there are no previous studies investigating 
the association between environmental factors and CRP values in children the same 
as in the present study. The present study showed no association between farming 
exposures and CRP values suggesting that the protective effect of farming is not 
related to increased production of CRP. However, the study confirmed the earlier 
findings of associations between low-grade inflammation and female gender, higher 
BMI and the season of the measurement (Chiriboga et al. 2009, Ford et al. 2001).  
In contrast, among non-atopic children at the age of 4.5 years, those who spent 
more time in stables had significantly lower levels of CRP, which is the opposite of 
the original hypothesis. It is always possible that children with higher CRP levels are 
recovering from infections and thus stay more inside their homes. Also, among 
atopic children at the age of 4.5 years, maternal smoking during the last two years 
seemed to associate with the low-grade inflammation at the age of 4.5 years. These 
results are in line with earlier findings in a mouse model study where microbes from 
damp building modulated the inflammatory reaction depending on the allergic status 
of the exposed mice (Leino et al. 2006). The results of the present study need to be 
confirmed but they do suggest that some environmental factors may associate with 
the low-grade inflammation in children, but the factors may differ between atopic 
and non-atopic children. More research is needed. 
At the age of one year, somewhat surprisingly, in the children who had already 
developed atopy by the age of one year, indicators of microbial exposure, i.e. farm 
milk consumption, exposure to dogs or both cats and dogs at home and mother’s 
visiting stables during pregnancy and recently were associated with low rather than 
high CRP levels at the age of one year. Thus, these findings further suggest that 
there might be a down-regulation or other alteration of inflammation as a response 
to microbial load that could be characteristic for the children who develop early 
atopy. These results support previous findings of the down-regulation of 
proinflammatory cytokines after exposure to Gram-negative bacteria (Lappalainen et 
al. 2008). Furthermore, this suggests that CRP does not always directly reflect the 
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microbial load but individual’s ability to respond to the inflammatory stimuli. This 
makes the interpretation of results challenging. 
The results do not exclude the possibility that the individuals with poor 
inflammatory response could get benefit from treatment that stimulates 
inflammation, such as suggested for some probiotic preparations (Marschan et al. 
2008), especially in environments where inflammatory pressure is low. The 
individuals with aberrant inflammatory response may be protected from allergic 
diseases in an environment where microbial load is high, but may be at risk of 
allergic immune reactios in an environment of high hygiene.  
The study proposes that the down-regulation of inflammatory response to 
environmental triggers of inflammation is a fundamental characteristic of the hosts’ 
immune response, which may predispose to the development of atopy. The ability of 
environmental factors to induce long term low-grade inflammation and the effects of 
long term low-grade inflammation on individuals remain still unknown. 
In conclusion, farming environment does not induce low-grade inflammation in 
children but some environmental factors associate with the low-grade inflammation 
in atopic and non-atopic children differently.  
The children who had siblings at the age of one year had higher CRP levels than 
the children who did not have siblings. In addition, the children who were in day 
care with children other than siblings at the age of one and 4.5 years tended to have 
higher CRP levels than children who were not in day care. These results support the 
findings of the original hygiene hypothesis (Strachan 1989). The contact with other 
children may provide different microbial exposure which could induce low-grade 
inflammation.  
6.1.2 Environmental factors and gut inflammation 
Faecal calprotectin levels associated with background factors indicating elevated 
environmental microbial load, and faecal calprotectin levels were significantly 
higher in the farmers’ children. These associations further suggest that farming 
environment induces intestinal inflammation likely due to increased microbial load.  
In addition to farming, consumption of breast milk at the age of two months 
associated with the levels of faecal calprotectin. The children who were exclusively 
breast-fed had the highest levels of faecal calprotectin. This implies that 
breastfeeding provides higher microbial exposure than bottle feeding. Bacteria in 
breast milk (Gueimonde et al. 2007) may result in elevated levels of faecal 
calprotectin by neutrophil infiltration due the stimulation of the gut immune system 
of the child.  
To evaluate the bacterial source that could induce the intestinal inflammation, the 
composition of gut microbiota were studied using 16S DNA pyrosequencing method 
of the 120 children of the study cohort. Relatively low faecal calprotectin levels in 
infants were associated with low amount of Lactobacilleae and this implies that 
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early colonisation with Lactobacilleae may lead to intestinal inflammation. The 
species of Lactobacillus have been shown to be capable of inducing the pro-
inflammatory IL-12 and IFN- ɣ production in murine dendritic cell cultures 
(Christensen et al. 2002) and IL-12 from human blood mononuclear cells (Hessle et 
al. 1999). Among infants with cow’s milk allergy and in infants with IgE-associated 
dermatitis, Lactobacillus rhamnosus GG (LGG) has been shown to increase IFN-ɣ 
production of stimulated human peripheral blood mononuclear cells (Pohjavuori et 
al. 2004). Some lactobacilli are able produce hydrogen-peroxide which may 
contribute intestinal inflammation (Hertzberger et al. 2014). It has been shown that 
the low-grade inflammation induced by probiotics could protect from allergies 
(Marschan et al. 2008). Instead, in this study the association between early intestinal 
inflammation and development of asthma in childhood was observed and intestinal 
inflammation associated with colonisation with Lactobacilleae.  
The infants who had very high faecal calprotectin levels, had low abundance of 
Escherichia in faeces. This result suggests that early Escherichia colonisation 
associates with down-regulation of intestinal inflammation. 
Different cells of the innate immune system, such epithelial cells, monocytes, 
macrophages and dendritic cells and in addition T-cells express toll-like receptors on 
their surfaces. Lipopolysaccharides (LPS) of Gram-negative bacteria, such as 
Escherichia, causes signalling via TLR-4 and activation of myeloid differentiation 
primary response 88 (MyD88) mediated pathway of cytokine production. It has been 
previously shown that continuous exposure to LPS causes tolerance and contributes 
to a down-regulation of TLR-4 signalling pathway (Hornef et al. 2002). That is why 
the early colonisation of the gut with Escherichia may contribute to a down-
regulation of TLR-4 signalling and moderations of inflammatory response which, in 
this study, was seen as low faecal calprotectin levels. It has been shown that also 
regulatory T-cells express TLR-4 (Caramalho et al. 2003), and an early colonisation 
with Escherichia could moderate inflammation via initiation of intestinal regulatory 
mechanisms. 
6.1.3 Moisture damage and induction of inflammation 
Moisture damage, mould and dampness have been reported to have adverse health 
effects (World Health Organization 2009) and suggested mechanism behind this 
phenomenon is induction of inflammation (Wolff 2011). The present study shows 
the association between moisture damage and mould in home and proinflammatory 
type responsiveness and systemic inflammation in children. Associations were 
assessed from the LUKAS participants for either CRP values, PI or LPS stimulated 
peripheral blood IL-1β, IL6 and TNF-α	  cytokines.  
Major moisture damage in child’s main living areas (living room, kitchen or 
child’s bedroom) was associated with high CRP levels and increased stimulated 
production of IL-1β at the age of six years. In addition, moisture damage with mould 
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in the bathroom associated with increased levels of proinflammatory cytokines in 
stimulated blood samples of six-year-old children. The results suggest that moisture 
damage or mould in home is capable of inducing systemic inflammation measured 
with CRP and further, causing the hyperresponsiveness of innate immunity 
measured with proinflammatory cytokines. These results support the earlier findings 
of moisture damage being able to induce systemic inflammation (Frankel et al. 2014, 
Punsmann et al. 2013a, Zhang et al. 2012).  
Few studies have tested inflammatory effects in association with moisture-
damaged buildings. One study found inflammatory markers in nasal lavage and 
induced sputum to be increased in subjects from moisture-damaged buildings 
compared with control buildings (Purokivi et al. 2001) and the present results are in 
line with this observation. Another study found that subjects who were exposed to 
moisture damage had altered receptor expression and inflammatory mediators 
released (Punsmann et al. 2013a) and similarly in the present study differences in 
cytokine production capacity was seen between children exposed and non-exposed 
to moisture damage or mould. However, there was no association between moisture 
damage and number of leucocytes in the present study, as seen in the previous study 
(Punsmann et al. 2013a). The number of leucocytes is a very rough estimate of 
inflammation in the body and consists of several subtypes such as lymphocytes, 
neutrophils, monocytes, eosinophils and basophils. Lymphocytes have been reported 
to increase due to moisture damage or mould (Leino et al. 2003), but this may not be 
reflected in the total number of leucocytes used in the present study. 
Despite various in vitro and mouse model studies of moisture damage and 
inflammation, our study is the first to show that damp homes induced systemic 
inflammation in children. The results are in line with the findings that moisture 
damage related agents can cause the induction of proinflammatory cytokines 
(Roponen et al. 2013, Wolff 2011). Cytokines IL-1β, IL-6 and TNF-α are known to 
be proinflammatory and in the study the levels of these cytokines were elevated 
possibly due to irritation associated with moisture damage and mould in home.  
Although several positive associations were observed between moisture damage 
and mould and respiratory symptoms, the associations were mostly non-significant 
and in many places conflicting. This was especially true for nasal symptoms, where 
conflicting significant associations, both positive and negative, were observed. The 
small sample size of the present study compared to most of the earlier studies on 
symptoms (Bornehag et al. 2001, Bornehag et al. 2004) may partly explain the 
observed results. 
This study showed that moisture damage and/or mould in home was associated 
with increased up-regulation of proinflammatory cytokines and increased levels of 
CRP in children. These results support the view that moisture damage and mould in 
home may be able to induce systemic inflammation and enhanced innate immunity 
responsiveness. The results are novel and need to be confirmed in future studies. 
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6.2 The association between inflammatory markers and 
allergic diseases 
Atopy 
Among non-atopic children increased CRP levels at age of one year were associated 
with a decreased risk for the development of atopy between the age of one and 4.5 
years, which supports the earlier findings of the protective effect of low-grade 
inflammation in the control of atopy (Viljanen et al. 2005). However, as discussed 
above, farm exposure was not associated with elevated CRP levels in the present 
study. In the previous studies of CRP as a marker of low-grade inflammation, the 
use of probiotics induced an increase in the values of CRP (Marschan et al. 2008, 
Viljanen et al. 2005), which suggests that environmental microbial load might be an 
important factor in the induction of inflammation-related protection from an allergic 
immune response. The clinical importance of early sensitisation to environmental 
allergens has been discussed, and it does not necessarily implicate allergic disease, 
instead it may be a normal physiological response to environmental antigens in 
infants (Rowe et al. 2007). The present results provide new insights in the hygiene 
hypothesis and give some support to the link between microbial load and allergic 
diseases but emphasizing the importance of adequate inflammatory response to the 
stimuli of microbial exposure in the regulation of the allergic reactivity.  
On the other hand, there was no strong evidence for an association between low-
grade inflammation at the age of 4.5 years and the prevalence of any atopy at the 
same age. However, the results suggest that CRP levels between the detection limit 
and the 75th percentile were associated with a decreased risk of atopic sensitisation 
to inhaled and seasonal allergens.  
It should be noted that in the study I, both CRP and specific IgE levels were 
measured at the same time. Earlier studies have found that low-grade intestinal 
inflammation at early infancy reduces the risk of allergic diseases later (Marschan et 
al. 2008, Viljanen et al. 2005) and the study II supports these findings. It might be 
that there is a window of opportunity in the early programming of the immune 
system, and the value of the CRP at the age of 4.5 years in the prediction of atopy 
may not be relevant anymore. 
These results are the very earliest findings on the associations between low-grade 
inflammation, measured with CRP values, and atopy in children and should be 
confirmed in the future.  
The study did not find an association between faecal calprotectin levels at the age 
of two months and atopy at the age of six years. The result is in line with the 
previous cross-sectional study that investigated the association between serum 
calprotectin levels and atopy (Cobanoglu et al. 2013). It might be that high faecal 
calprotectin and neutrophil infiltration in the intestine during the early life modulates 
the factors affecting the development of allergic diseases but not factors regulating 
IgE response such as IL-4 and IL-13 cytokines. 
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Asthma and atopic dermatitis 
There were no significant associations between the CRP values at the age of one 
year and the development of atopic dermatitis or asthma/asthmatic bronchitis 
between ages one and four years. There are no previous studies to compare these 
results. The low number of children developing atopic dermatitis and asthma or 
asthmatic bronchitis between ages one and four years is the fact that makes the 
interpretation of the results difficult in the present study. 
The study revealed that high levels of faecal calprotectin at the age of two 
months predicts asthma and atopic dermatitis by the age of six years thus indicating 
long term effects of early intestinal inflammation on the development of allergic 
diseases. There were no linear association between levels of faecal calprotectin and 
allergic diseases, only high levels of faecal calprotectin were associated with asthma 
and atopic dermatitis at later age.  
The results are different from earlier findings that faecal calprotectin levels in 
first months of life did not associate with the allergic diseases at the age of two years 
(Baldassarre et al. 2011). In the present study the association between faecal 
calprotectin and allergic diseases were evaluated up to six years of age, while the 
age of two years might be too young for allergic diseases to be manifested as seen in 
the previous study. 
6.3 Methodological considerations 
Study population 
The major strengths in the study populations are the prospective study designs which 
provide large amounts of information on children’s prenatal, infant, and childhood 
environments. In the PASTURE study there were 1133 and in the LUKAS study 442 
children included. The number of the children in the study is sufficient to observe 
environmental factors and health effects. As single observational studies can provide 
only limited support for causal relationships, the findings should be confirmed by 
new observational, mechanistic and finally experimental studies. 
There are always difficulties to follow the whole study population in cohort 
studies through the years. The amount of drop-outs was not a problem in the 
PASTURE study, 934 (82 %) of the children participated in the six-year follow-up. 
However, in the LUKAS study there were data on home inspections only for 309 
(69.9 %) homes at six year follow-up. In addition, the blood samples were not 
available from the total study populations. 
In the PASTURE study, half of the children are from rural areas and half from 
farms. This allowed for the comparisons of farmer and nonfarmer effects with a 
wide range of collected data on the early living environment. The farming 
environment provides a good opportunity to evaluate the effect of specific 
environmental exposures to the immune system and children’s allergic diseases. 
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However, farming environment differs from country to country (von Mutius and 
Radon 2008) which might be one reason for the differences between countries. Even 
though multi-center studies like the PASTURE study are carried out with identical 
protocols in all countries, the use of different languages and different diagnostic 
criteria of allergic diseases and asthma inevitably lead to some incoherence in the 
data. The study cohort or the study centre and farming were always included as 
confounding factors in the statistical models because there were differences between 
the LUKAS1 and LUKAS2 cohorts as well as between countries in the PASTURE 
cohort and in addition between farmers and non-farmers. 
Some of the exposure assessments of environmental determinants were mainly 
based on self-reported questionnaires but exposure assessments were carried out via 
questionnaires at each time point, which is one of the strengths of the study. The 
exposures were assessed during early childhood, which is an important time for the 
development of the immune system (von Mutius and Vercelli 2010). In addition, 
some information was available from the time of pregnancy and two months after 
the delivery and that provides evidence of the environmental exposures in utero.  
 
Asthma determination 
Asthma is not a single disease and the characterisation of different asthma is 
challenging due to the several phenotypes (GINA 2012). In addition, asthma is 
diagnosed somewhat differently in different countries. Especially, the determination 
of asthmatic or obstructive bronchitis varies greatly between nations. It should also 
be noted that the information of the asthma diagnosis was collected via parent 
reported questionnaires instead of clinical examination. This might cause 
information bias in the study. Also, the definition of asthma used in the study was 
cumulative over time meaning that the definition inevitably includes also some 
children with transient wheezing. 
 
Moisture damage 
The fact that a trained civil engineer made the home inspections is one of the main 
strengths of the LUKAS study. Moisture damage or mould were recorded and 
allocated in each room separately (Karvonen et al. 2009).  
The results of this study show that the location of the moisture damage or mould 
in the home is relevant as was suggested previously (Pekkanen et al. 2007). The 
significant associations with proinflammatory cytokines were seen for moisture 
damage or mould in the child’s main living areas (in the kitchen, livingroom or 
child’s bedroom) and in the bathroom.  
The results of the home inspections were informed to the parents. It might be that 
the families with asthmatic children in homes with moisture damage/mould 
problems pay more attention to respiratory symptoms and that is why the children 
who had asthma diagnosis were excluded from the analyses of moisture damage and 
respiratory symptoms. 
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Inflammatory markers 
There are multiple factors affecting the expression of inflammatory markers in the 
system. It is possible that a one-time measurement of the inflammatory markers is 
not sufficiently stable marker of the status of the immune system. However, to 
reduce the possible effect of background factors on inflammatory markers, all 
relevant confounders were intended to include in the statistical models. Viruses are 
often present in nasopharyngeal samples taken from healthy children. In the study 
there was neither clinical examination by a doctor nor viral sample collection of the 
children during the time of the blood extractions at any time point and thus there is a 
possibility that some children were suffering viral infection which on the other hand 
could have affected the cytokine levels and other inflammatory markers. It may also 
be that atopic children are more susceptible to viral infections which could affect the 
inflammatory markers. To reduce the possible effect of infections the children who 
had elevated CRP values indicating acute infection were excluded from the analyses. 
The strength of the study is that there were results of various proinflammatory 
cytokines induced by different stimulations and CRP values at the same time point 
available. This provides the possibility to investigate the association between 
moisture damage and inflammation extensively and this study is the first one to 
investigate this association in children. The cytokine responses were assessed using 
whole blood samples. Whole blood culture contains circulating plasma components 
which may have an effect on specific stimulants. When using whole blood culture 
the precise number of leucocytes in different stimulation is not identical between 
individuals. Individual variation was controlled by standardising the measured 
cytokine concentration by the number of leucocytes. 
Faecal calprotectin levels were measured at the age of two months. At this age, 
the immune system is immature and the gut is permeable. Moreover, the normal 
flora is not fully established yet. In normal state calprotectin levels are high in 
infancy and there are no accurate level for the elevated calprotectin that indicates a 
disease in the gut. A reference value of 50 µg/g calprotectin in faeces is used for 
healthy adults and children aged from four to 17 years according to the previous 
findings (Fagerberg et al. 2003). Levels of calprotectin were shown to be remarkably 
higher in infants under the age one month (Baldassarre et al. 2007) and, in general, 
approximately five times higher during the neonatal period than in adults or children 
over four years of age (Kapel et al. 2010). 
6.4. Future perspectives 
The LUKAS and PASTURE birth cohorts are ongoing studies and future follow-ups 
will give more information on the association between early environment, immune 
system and allergic diseases during childhood. Longer follow-ups will also provide 
the possibility to investigate the long-term effects of moisture damage and mould 
problems in home and immune system and allergic diseases later in life.  
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In the future there is a possibility to investigate the effect of the low-grade 
inflammation on the immune system later in life and the long term effects of the 
low-grade inflammation on the allergic diseases. Also, the association between 
moisture damage in infancy and inflammatory markers at the age of six years will be 
investigated. 
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7 CONCLUSIONS 
Based on the results presented in this thesis, following conclusions can be drawn: 
 
1. The present study was able to show associations between environmental factors 
and serum CRP levels. However, the results suggest that the role played by 
environmental factor in low-grade inflammation may differ between atopic and 
non-atopic children and be different at different ages. Farming environment did 
not significantly induce systemic low-grade inflammation but was associated 
with intestinal inflammation in children.  
 
2. The study suggests that moisture damage or mould at home may be capable of 
increasing the levels of proinflammatory cytokines in peripheral blood of 
children. 
 
3. Systemic low-grade inflammation measured with serum CRP at early age may 
protect from atopy later in life. This raises the hypothesis that the down-
regulation of inflammatory response to environmental triggers of inflammation 
may be a fundamental characteristic of the immune response of a host, 
predisposed to the development of atopy.  
 
4. The results suggest that intestinal inflammation at early life predicts the 
development of allergic diseases later in life. The results also suggest that the 
early microbial colonization is an important regulator of the intestinal 
inflammation. 
 
The present study shows the protective role of low-grade inflammation from atopy. 
The study provides new perspective to the development of allergic diseases by 
showing that intestinal inflammation during the first months of life, predicts asthma 
and atopic dermatitis. Furthermore, the present study shows the association between 
moisture damage and mould in home and hyperresponsiveness of the innate 
immunity in children. These results are novel and need to be confirmed in the future. 
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